Processing 00000000.tx.1: Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B Guang-hui Wang1,2, Noriko Sawai1, Svetlana Kotliarova1, Ichiro Kanazawa2 and Nobuyuki Nukina1,+ 1Laboratory for CAG Repeat Diseases, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama, 351-0198, Japan and 2Department of Neurology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan Received 13 March 2000; 

Phrase: "Ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "the MJD1 gene product,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "interacts with the two human homologs of yeast DNA repair protein RAD23,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   770   C1325316:DNA repair protein [Molecular Function]
   770   C1366764:DNA repair protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C0254235:RAD23 protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0012899:DNA Repair [Genetic Function]
   751   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0872306:Yeast Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1159338:protein repair [Molecular Function]
   736   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0036025:yeast [Fungus]
   736   C0043240:Repair, NOS [Organism Function]
   736   C0043392:Yeast [Food]
   736   C0043393:Yeast [Fungus]
   736   C0086418:Human [Human]
   736   C0205448:Two [Quantitative Concept]
   736   C0374711:Repair [Therapeutic or Preventive Procedure]
   736   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   734   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   703   C1334043:Homolog [Gene or Genome]

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B Guang-hui Wang1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Noriko Sawai1,"

Phrase: "Svetlana Kotliarova1,"

Phrase: "Ichiro Kanazawa2"

Phrase: "and"

Phrase: "Nobuyuki Nukina1,"

Phrase: "+ 1Laboratory for CAG Repeat Diseases,"

Phrase: "RIKEN Brain Science Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "2-1 Hirosawa,"

Phrase: "Wako-shi,"

Phrase: "Saitama,"

Phrase: "351-0198,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "2Department of Neurology,"

Phrase: "Graduate School of Medicine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "7-3-1,"

Phrase: "Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "13 March 2000"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted 16 May 2000.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "16 May 2000."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  MachadoJoseph disease (MJD) is an autosomal dominant neurodegenerative disorder caused by an expansion of the polyglutamine tract near the C-terminus of the MJD1 gene product, ataxin-3. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MachadoJoseph disease (MJD)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "an autosomal dominant neurodegenerative disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   812   C0012634:Disorder [Disease or Syndrome]

Phrase: "caused by an expansion of the polyglutamine tract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   744   C1185740:Tract [Body Part, Organ, or Organ Component]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "near the C-terminus"

Phrase: "of the MJD1 gene product,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.4: The mutant ataxin-3 forms intranuclear inclusions in cultured cells as well as in diseased human brain and also causes cell death in transfected cells. 

Phrase: "The mutant ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "intranuclear inclusions in cultured cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1366904:Intranuclear Inclusions [Cell Component]
   797   C0205708:cells inclusions [Cell Component]
   726   C1512693:Inclusion [Qualitative Concept]

Phrase: "as well as in diseased human brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0205170:Well [Qualitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "also"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death in transfected cells."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007587:Cell Death [Cell Function]
           cells death
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.5: However, the normal function of ataxin-3 remains unknown. 

Phrase: "However,"

Phrase: "the normal function of ataxin-3 remains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.6: To explore the function of ataxin-3, we used the two-hybrid system to screen for the protein(s) that interacts with ataxin-3. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the function of ataxin-3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the two-hybrid system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "screen for the protein(s"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418948:PROTEIN S [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220908:screen [Health Care Activity]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]

Phrase: ")"

Phrase: "that"

Phrase: "interacts with ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.7: We found that ataxin-3 interacts with two human homologs of the yeast DNA repair protein RAD23, HHR23A and HHR23B. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts with two human homologs of the yeast DNA repair protein RAD23,"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   770   C1325316:DNA repair protein [Molecular Function]
   770   C1366764:DNA repair protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C0254235:RAD23 protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0012899:DNA Repair [Genetic Function]
   751   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0872306:Yeast Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1159338:protein repair [Molecular Function]
   736   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0036025:yeast [Fungus]
   736   C0043240:Repair, NOS [Organism Function]
   736   C0043392:Yeast [Food]
   736   C0043393:Yeast [Fungus]
   736   C0086418:Human [Human]
   736   C0205448:Two [Quantitative Concept]
   736   C0374711:Repair [Therapeutic or Preventive Procedure]
   736   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   734   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   703   C1334043:Homolog [Gene or Genome]

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]
Processing 00000000.tx.8: Furthermore, we confirmed that ataxin-3 interacts with the ubiquitin-like domain at the N-terminus of the HHR23 proteins, which is important for nucleotide excision repair; 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts with the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "at the N-terminus"

Phrase: "of the HHR23 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "important for nucleotide excision repair"

Phrase: ";"
Processing 00000000.tx.9: however, ataxin-3 does not interact with ubiquitin, implying that ataxin-3 might be functionally associated with the HHR23 proteins through this specific interaction. 

Phrase: "however,"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "implying"

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "might"

Phrase: "be"

Phrase: "functionally"

Phrase: "associated with the HHR23 proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "through this specific interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.10: The normal and mutant ataxin-3 proteins show no difference in their ability to bind to the HHR23 proteins. 

Phrase: "The normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no difference in their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "bind to the HHR23 proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
Processing 00000000.tx.11: However, in 293 cells HHR23A is recruited to intranuclear inclusions formed by the mutant ataxin-3 through its interaction with ataxin-3. 

Phrase: "However,"

Phrase: "in 293 cells HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419236:HHR23A [Gene or Genome]

Phrase: "is"

Phrase: "recruited to intranuclear inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1366904:Intranuclear Inclusions [Cell Component]
   737   C1512693:Inclusion [Qualitative Concept]

Phrase: "formed by the mutant ataxin-3"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C1538301:ATAXIN 3 [Gene or Genome]
   753   C0205431:Formed [Functional Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "through its interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.12: These results suggest that this interaction is associated with the normal function of ataxin-3 and that some functional abnormality of the HHR23 proteins might exist in MJD.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "associated with the normal function of ataxin-3"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1538301:ATAXIN 3 [Gene or Genome]
   767   C1292719:Associated function [Functional Concept]
   744   C0031843:function [Physiologic Function]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
   744   C2347086:% Normal [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "that"

Phrase: "some functional abnormality of the HHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704258:Abnormality [Finding]
   738   C0311448:abnormal proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "exist in MJD."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C2987476:Exist [Conceptual Entity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  MachadoJoseph disease (MJD) is an autosomal dominant neurodegenerative disorder which is characterized clinically by cerebellar ataxia, pyramidal and extrapyramidal signs, peripheral neuropathy and ophthalmoplegia (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MachadoJoseph disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "an autosomal dominant neurodegenerative disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   812   C0012634:Disorder [Disease or Syndrome]

Phrase: "which"

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "clinically by cerebellar ataxia,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0007758:Cerebellar Ataxia [Sign or Symptom]
   770   C0004134:Ataxia [Sign or Symptom]
   770   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   770   C1707522:Cerebellar [Tissue]

Phrase: "pyramidal"

Phrase: "and"

Phrase: "extrapyramidal signs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0234133:Extrapyramidal signs [Sign or Symptom]
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "peripheral neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031117:Peripheral Neuropathy [Disease or Syndrome]
   861   C0205100:Peripheral [Spatial Concept]
   861   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "and"

Phrase: "ophthalmoplegia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029089:Ophthalmoplegia [Sign or Symptom]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: The gene for MJD has been mapped to the long arm of chromosome 14 (14q24.3q32.1) (2), cloned and designated MJD1. 

Phrase: "The gene for MJD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1416989:MAL gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "mapped to the long arm of chromosome 14"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C1276871:Long arm of chromosome [Cell Component]
   819   C1327813:Chromosome 14 Long Arm [Nucleotide Sequence]
   800   C0449721:Arm of chromosome [Nucleotide Sequence]
           Chromosome Arm
   770   C0008656:Chromosome 14 [Cell Component]
   770   C0575519:Long arm [Finding]
   750   C0814036:chromosome map [Intellectual Product]
   744   C0008633:Chromosome [Cell Component]
   744   C0205166:Long [Qualitative Concept]
   744   C0446516:Arm [Body Location or Region]
   744   C1269078:Arm [Body Part, Organ, or Organ Component]
   744   C1269612:Arm [Body Location or Region]
   744   C1706317:Long [Qualitative Concept]
   711   C0024779:Map [Manufactured Object]
   711   C1706473:Map [Conceptual Entity]

Phrase: "(14q24.3q32.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1520593:14q24.1 [Cell Component]
   827   C1520591:14q24 [Cell Component]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "designated MJD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538301:MJD1 [Gene or Genome]
Processing 00000000.tx.15: The MJD1 gene product, called ataxin-3, has unstable CAG repeats located near the C-terminus (3). 

Phrase: "The MJD1 gene product,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "called ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "has"

Phrase: "unstable CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "located near the C-terminus"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: In normal individuals the number of repeats ranges between 13 and 36, whereas in affected individuals this range is expanded to 6282 (3,4). 

Phrase: "In normal individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "the number of repeats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "ranges between 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514721:*Ranges [Quantitative Concept]
   790   C2348147:Range [Quantitative Concept]
   790   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "36,"

Phrase: "whereas in affected individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "this range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "is"

Phrase: "expanded to 6282"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205229:expanded [Spatial Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.17: The MJD1 gene is widely expressed in the brain of normal and affected individuals, preferentially in neurons (5). 

Phrase: "The MJD1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "widely"

Phrase: "expressed in the brain of normal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "affected individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "preferentially in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: Ataxin-3 is a protein of unknown function, with a predicted molecular weight of 42 kDa (3). 

Phrase: "Ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "is"

Phrase: "a protein of unknown function,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0815043:function protein [Amino Acid, Peptide, or Protein]
   797   C1527118:Protein Function [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with a predicted molecular weight"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   755 E C0567416:Molecule [Substance]

Phrase: "of 42 kDa (3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: Both the normal and mutant ataxin-3 proteins are expressed ubiquitously. 

Phrase: "Both"

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed"

Phrase: "ubiquitously."
Processing 00000000.tx.20: In brain, certain regions, such as the striatum, express ataxin-3 in a limited subset of neurons (6). 

Phrase: "In brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "certain regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "such as the striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "express"

Phrase: "ataxin-3 in a limited subset of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.21: Both the normal and mutant forms of ataxin-3 are expressed at similar levels in MJD lymphoblastoid cell lines (7). 

Phrase: "Both"

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant forms of ataxin-3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "expressed at similar levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441889:Levels [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in MJD lymphoblastoid cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   851   C0682526:lymphoblastoid cell line [Cell]
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.22: Studies have shown that ataxin-3 is located in the cytoplasm (6) or in both the cytoplasm and nucleus (7). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "is"

Phrase: "located in the cytoplasm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasm [Cell Component]

Phrase: "(6"

Phrase: ")"

Phrase: "or in both"

Phrase: "the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.23: Furthermore, a potential nuclear localization signal has been identified in normal ataxin-3 and that study also showed that ataxin-3 is transported into the nucleus and associated with the nuclear matrix in COS-7 as well as neuroblastoma cells (8). 

Phrase: "Furthermore,"

Phrase: "a potential nuclear localization signal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0525021:Nuclear Localization Signal [Amino Acid Sequence]
   812   C0475264:Localisation [Functional Concept]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1710082:Signal [Phenomenon or Process]
   812   C1744691:localisation [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "identified in normal ataxin-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205307:Normal [Qualitative Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "that study also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "is"

Phrase: "transported into the nucleus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1526989:nucleus transport [Cell Function]
   770   C0007610:Nucleus [Cell Component]
   737   C0005528:Transport, NOS [Cell Function]
   737   C1317949:Transport [Manufactured Object]
   737   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "associated with the nuclear matrix"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0028581:Nuclear Matrix [Cell Component]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0521447:Nuclear [Spatial Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in COS-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454802:Cos [Geographic Area]

Phrase: "as well as"

Phrase: "neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.24: CSM14.1 cells expressing recombinant normal ataxin-3 or mutant ataxin-3 show cytoplasmic and strong nuclear staining (9). 

Phrase: "CSM14.1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "recombinant normal ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "or"

Phrase: "mutant ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "strong nuclear staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.25: Moreover, overexpression of expanded full-length ataxin-3 causes cell death and the formation of intranuclear inclusions (9). 

Phrase: "Moreover,"

Phrase: "overexpression of expanded full-length ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the formation of intranuclear inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.26: An expanded polyglutamine fragment of ataxin-3 also leads to cell death (10) and the formation of intranuclear inclusions (11,12). 

Phrase: "An expanded polyglutamine fragment of ataxin-3 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "leads to cell death"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "the formation of intranuclear inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.27: Although MJD is one of eight neurodegenerative disorders caused by an expansion of CAG repeats in the affected gene and by an increase in the length of the corresponding polyglutamine domain in the gene-encoded protein (13), the physiological and biochemical functions of ataxin-3 remain unknown. 

Phrase: "Although"

Phrase: "MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "one of eight neurodegenerative disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "caused by an expansion of CAG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "repeats in the affected gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017337:Gene [Gene or Genome]
   760   C0205341:Repeat [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]

Phrase: "and by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "in the length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "of the corresponding polyglutamine domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "in the gene-encoded protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "the physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "biochemical functions of ataxin-3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0205474:Biochemical [Functional Concept]
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "remain"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.28: To explore the normal function of ataxin-3, we undertook a yeast two-hybrid screen to isolate proteins that interact directly with ataxin-3. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the normal function of ataxin-3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "undertook"

Phrase: "a yeast two-hybrid screen to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0599647:Two Hybrid [Molecular Biology Research Technique]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0205448:Two [Quantitative Concept]
   804   C0220908:screen [Health Care Activity]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C1305399:screen [Functional Concept]
   804   C1705053:Screen [Medical Device]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "interact"

Phrase: "directly with ataxin-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1538301:ATAXIN 3 [Gene or Genome]
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.29: We report here that two human homologs of the yeast DNA repair protein RAD23, HHR23A and HHR23B, interact with both normal and mutant ataxin-3. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "that two human homologs of the yeast DNA repair protein RAD23,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   704   C1334043:Homolog [Gene or Genome]

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "interact with both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.30: Furthermore, we confirmed that both HHR23A and HHR23B interact with ataxin-3 through their N-terminal ubiquitin-like (UBL) domain. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "both HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "interact with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "through their N-terminal ubiquitin-like (UBL) domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.31: Interestingly, HHR23A co-localizes with aggregates formed by mutant ataxin-3 and thus may participate in pathological processes.  

Phrase: "Interestingly,"

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "co-localizes with aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205418:aggregates [Qualitative Concept]
   770   C0392752:localize [Spatial Concept]

Phrase: "formed by mutant ataxin-3"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205431:Formed [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "participate in pathological processes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0030660:Pathological Processes [Pathologic Function]
   797 E C0677042:Pathology processes [Pathologic Function]
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C1521733:Pathological [Functional Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.32: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Isolation of HHR23A by yeast two-hybrid screen Using ataxin-3 as bait, a human fetal brain cDNA library was screened by sequential transformation. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Isolation of HHR23A"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "by yeast two-hybrid screen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0220908:screen [Health Care Activity]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1305399:screen [Functional Concept]
   812   C1705053:Screen [Medical Device]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ataxin-3 as bait,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "a human fetal brain cDNA library"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0440731:Fetal brain [Embryonic Structure]
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0015965:Fetal [Embryonic Structure]
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0521457:Fetal [Functional Concept]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "screened by sequential transformation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0040682:Transformation [Cell Function]
   770   C1510411:Transformation [Pathologic Function]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705163:Transformation [Research Activity]
   770   C1705294:Sequential [Qualitative Concept]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]
Processing 00000000.tx.33: Of ~2 x 106 resulting transformants, four were true positives, identified by retransformation into yeast cells harboring pAS2-1-MJD-CAG20, pAS2-1-MJD-CAG68 or pAS2-1-MJD-CAG80 and growth on SD-Trp-Leu-His selective plates with 5 mM 3-amino-1,2,4-triazole (3-AT) and a positive result in -galactosidase (-gal) filter assays. 

Phrase: "Of ~2 x 106 resulting transformants,"

Phrase: "four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "were"

Phrase: "true positives,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0205559:True positive [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "identified by retransformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "into yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "pAS2-1-MJD-CAG20,"

Phrase: "pAS2-1-MJD-CAG68"

Phrase: "or"

Phrase: "pAS2-1-MJD-CAG80"

Phrase: "and"

Phrase: "growth on SD-Trp-Leu-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "His selective plates with 5 mM 3-amino-1,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C1139930:plates [Medical Device]
   708 E C0005971:Plate [Medical Device]
   708 E C3537155:Plate [Manufactured Object]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4-triazole (3-AT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040880:Triazole [Organic Chemical]

Phrase: "and"

Phrase: "a positive result in -galactosidase (-gal) filter assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.34: The plasmids of these four yeast clones were isolated and sequenced. 

Phrase: "The plasmids of these four yeast clones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.35: One of the plasmids, named pACT2-EB202, carrying an ~1.3 kb cDNA insert, was confirmed to contain the full-length HHR23A cDNA. 

Phrase: "One of the plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "named pACT2-EB202,"

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "an ~1.3 kb cDNA insert,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441587:Insert [Health Care Activity]
   804   C1743766:Insert [Medical Device]
   804   C1883719:Insert [Functional Concept]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the full-length HHR23A cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.36: The full-length HHR23A protein interacted specifically with ataxin-3-Q20, ataxin-3-Q68 and ataxin-3-Q80, but did not interact with the GAL4-binding domain (GAL4-BD) expressed by the empty GAD4-BD vector pAS2-1 (Fig. 1A). 

Phrase: "The full-length HHR23A protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacted"

Phrase: "specifically with ataxin-3-Q20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "ataxin-3-Q68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin-3-Q80,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with the GAL4-binding domain (GAL4-BD)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1416832:GAL4 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "expressed by the empty GAD4-BD vector pAS2-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0625647:BD-1 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0442335:Vector [Spatial Concept]
   742   C1705099:Vector [Idea or Concept]
   742   C1880497:Empty [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.37: The three other clones are currently being characterized. 

Phrase: "The three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "other clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "being"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.38: View larger version (48K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.39: Interaction of HHR23A (A) and HHR23B (B) with ataxin-3 using the yeast two-hybrid system. 

Phrase: "Interaction of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "(B) with ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0378071:b-3 [Organic Chemical,Pharmacologic Substance]
   770   C2347469:/B [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid system."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.40: Yeast cells co-transformed with GAL4-BD vectors with or without the MJD gene and GAL4-AD vectors with or without the HHR23 gene were grown on His+ plates. 

Phrase: "Yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transformed with GAL4-BD vectors"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   774   C2610644:CO binding [Molecular Function]
   748   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0442335:Vectors [Spatial Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1510411:Transformed [Pathologic Function]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   714 E C1705099:Vector [Idea or Concept]

Phrase: "with"

Phrase: "or without the MJD gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1416989:MAL gene [Gene or Genome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "GAL4-AD vectors with"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vectors [Spatial Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "or without the HHR23 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "grown on His+ plates."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1139930:plates [Medical Device]
   770   C1412323:HIS [Gene or Genome]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.41: The resultant clones were streaked onto His+ and His plates. 

Phrase: "The resultant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "streaked onto His+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1412323:HIS [Gene or Genome]
   756   C2348542:Streak [Idea or Concept]

Phrase: "and"

Phrase: "His plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.42: -gal assays for positive colonies were performed using NC 45 membrane filters (Schleicher and Schuell, Eschborn, Germany). 

Phrase: "-gal assays for positive colonies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NC 45 membrane filters"
Meta Candidates (Total=15; Excluded=11; Pruned=0; Remaining=4)
   812   C0025255:Membrane [Tissue]
   812   C0180860:Filters [Manufactured Object]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   779 E C0581406:Filter [Medical Device]
   779 E C1522664:Filter [Intellectual Product]
   779 E C1704449:Filter [Conceptual Entity]
   779 E C1704684:Filter [Medical Device]
   779 E C1875155:FILTER [Medical Device]
   756 E C0080194:Strain [Injury or Poisoning]
   756 E C0442694:Straining [Physiologic Function]
   756 E C0456178:strain [Intellectual Product]
   756 E C1518614:Strain [Organism]
   756 E C2987481:Strain [Mental Process]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Schleicher"

Phrase: "and"

Phrase: "Schuell,"

Phrase: "Eschborn,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.43: The clones were negative for -gal activity and could not grow on His plates without MJD genes being present in the GAL4-BD vector or without HHR23 genes in the GAL4-AD vector (A, lanes 14, and B, lane 1). 

Phrase: "The clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "negative for -gal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "grow on His plates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1139930:plates [Medical Device]
   770   C1412323:HIS [Gene or Genome]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "without MJD genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   856   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "being"

Phrase: "present in the GAL4-BD vector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "or without HHR23 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "in the GAL4-AD vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "(A,"

Phrase: "lanes 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.44: Clones co-transformed with pAS2-1-MJDs and pACT2-HHR23A or pACT2-HHR23B showed positive -gal activity and grew on His plates (A, lanes 57, and B, lanes 24), indicating that HHR23A and HHR23B specifically interacted with ataxin-3, independent of polyglutamine length. 

Phrase: "Clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "co-transformed with pAS2-1-MJDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510411:Transformed [Pathologic Function]

Phrase: "and"

Phrase: "pACT2-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "or"

Phrase: "pACT2-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "positive -gal activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "grew on His plates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1139930:plates [Medical Device]
   770   C1412323:HIS [Gene or Genome]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "(A,"

Phrase: "lanes 57,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lanes 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "interacted with ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "independent of polyglutamine length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.45: Positive (A, lane 9, and B, lane 6) and negative controls (A, lane 8, and B, lane 5) are also shown. 

Phrase: "Positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "(A,"

Phrase: "lane 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "negative controls"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(A,"

Phrase: "lane 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "are"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.46: Liquid -gal assays were performed using ONPG as substrate. 

Phrase: "Liquid -gal assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ONPG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]
   812   C0439114:O NOS [Intellectual Product]

Phrase: "as substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.47: Each column represents the mean SE (bars) values of four measurements.  

Phrase: "Each column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean SE (bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1707156:BARS [Gene or Genome]
   827   C3274014:BARS [Intellectual Product]
   827   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "values of four measurements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0042295:Values [Qualitative Concept]
   737 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.48: In humans there are two genes, HHR23A and HHR23B, with sequence homology to Saccharomyces cerevisiae RAD23 (14). 

Phrase: "In humans there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "are"

Phrase: "two genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "with sequence homology"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0162775:Sequence Homology [Quantitative Concept]
   950 E C0162774:Sequence Homolog [Molecular Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1334043:Homology [Gene or Genome]
   861   C1519249:Sequence [Functional Concept]
   861   C2697616:Homology [Qualitative Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "to Saccharomyces cerevisiae RAD23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0036025:Saccharomyces cerevisae [Fungus]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.49: Both HHR23A and HHR23B have a UBL domain at the N-terminus and a xeroderma pigmentosum group C (XPC)-binding domain near the C-terminus (15). 

Phrase: "Both HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "have"

Phrase: "a UBL domain at the N-terminus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "a xeroderma pigmentosum group C (XPC)-binding domain near the C-terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.50: Since HHR23A interacts with ataxin-3, we decided to examine whether HHR23B does as well. 

Phrase: "Since"

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "interacts with ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "does as well."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205170:Well [Qualitative Concept]
   790   C1272751:Does [Finding]
   790   C2828361:Does [Activity]
   790   C3146287:Well [Manufactured Object]
Processing 00000000.tx.51: To this end, we cloned the full-length HHR23B gene from a human fetal spleen cDNA library and tested the binding of HHR23B and ataxin-3 using the two-hybrid system. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the full-length HHR23B gene from a human fetal spleen cDNA library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C0017272:Gene Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   751   C0314604:Human gene [Gene or Genome]
   736   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the binding of HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the two-hybrid system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0599647:Two Hybrid [Molecular Biology Research Technique]
Processing 00000000.tx.52: The results showed that HHR23B also interacts with ataxin-3 (Fig. 1B). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that HHR23B also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "interacts with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: Liquid -gal assays showed that there is no difference in this interaction dependent on polyglutamine length (Fig. 1). 

Phrase: "Liquid -gal assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "is"

Phrase: "no difference in this interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "dependent on polyglutamine length"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.54: To determine which domain of ataxin-3 interacts with the HHR23 proteins, we created several deletion mutants of normal ataxin-3 (Fig. 2). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which domain of ataxin-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "interacts with the HHR23 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "several deletion mutants of normal ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C2594860:mutant/normal [Clinical Attribute]
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.55: We examined the interaction of these deletion mutants of ataxin-3 with the HHR23 proteins using the two-hybrid system. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the interaction of these deletion mutants of ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "with the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the two-hybrid system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0599647:Two Hybrid [Molecular Biology Research Technique]
Processing 00000000.tx.56: Both HHR23A and HHR23B interact with the N-terminal fragment of ataxin-3, which does not contain polyglutamine (Fig. 2). 

Phrase: "Both HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "interact with the N-terminal fragment of ataxin-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1538301:ATAXIN 3 [Gene or Genome]
   742   C0205088:Terminal [Temporal Concept]
   742   C0332255:fragment [Functional Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "polyglutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.57: View larger version (14K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.58: The interaction domain of ataxin-3 with the HHR23 proteins. 

Phrase: "The interaction domain of ataxin-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "with the HHR23 proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.59: Yeast cells co-transformed with GAL4-BD vector with deletion mutants of ataxin-3 and GAL4-AD vectors with the HHR23 genes were grown on His+ plates. 

Phrase: "Yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transformed with GAL4-BD vector"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C2610644:CO binding [Molecular Function]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0442335:Vector [Spatial Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1510411:Transformed [Pathologic Function]
   748   C1705099:Vector [Idea or Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "with deletion mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "of ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "GAL4-AD vectors with the HHR23 genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442335:Vectors [Spatial Concept]
   711 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "grown on His+ plates."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1139930:plates [Medical Device]
   770   C1412323:HIS [Gene or Genome]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.60: The resultant clones were streaked onto His+ and His plates for further examination. 

Phrase: "The resultant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "streaked onto His+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1412323:HIS [Gene or Genome]
   756   C2348542:Streak [Idea or Concept]

Phrase: "and"

Phrase: "His plates for further examination."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1139930:plates [Medical Device]
   726 E C0005971:Plate [Medical Device]
   726 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.61: Clones expressing the N-terminal fragment of ataxin-3 (lane 1) and the HHR23 proteins showed positive -gal activity. 

Phrase: "Clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "the N-terminal fragment of ataxin-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragment [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "positive -gal activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.62: No positive -gal activity was detected in clones expressing the middle (lane 2) or C-terminal fragment of ataxin-3 (lane 3) and the HHR23 proteins. 

Phrase: "No positive -gal activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "detected in clones"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0009013:Clones [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C1522642:Clone [Tissue]
   706 E C1704387:Clonal [Qualitative Concept]

Phrase: "expressing"

Phrase: "the middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "C-terminal fragment of ataxin-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0332255:fragment [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the HHR23 proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.63: Positive (lane 5) and negative (lane 4) controls are also shown.  

Phrase: "Positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "(lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.64: In vitro interaction of the HHR23 proteins with normal and mutant ataxin-3 To assess the specificity of the interaction between ataxin-3 and the HHR23 proteins, we evaluated the binding of glutathione S-transferase (GST)HHR23A with normal and mutant recombinant ataxin-3 or native ataxin-3 in vitro. 

Phrase: "In vitro interaction of the HHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "with normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3 To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the specificity of the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "between ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "the HHR23 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the binding of glutathione S-transferase (GST)HHR23A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1623443:glutathione binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "with normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant recombinant ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "or"

Phrase: "native ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.65: Recombinant ataxin-3 containing 20, 68 or 80 glutamines expressed by vector pET-21a(+) in Escherichia coli was tested for binding with GST alone or GSTHHR23A coupled to glutathioneagarose beads. 

Phrase: "Recombinant ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "or"

Phrase: "80 glutamines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "expressed by vector pET-21a"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031268:Pet [Animal]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1553659:21a [Medical Device]
   760   C1705099:Vector [Idea or Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "in Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014834:Escherichia coli [Bacterium]
   861   C0014833:Escherichia [Bacterium]

Phrase: "was"

Phrase: "tested for binding"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C0392366:tested [Intellectual Product]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "GSTHHR23A"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "to glutathioneagarose beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.66: All recombinant ataxin-3-Q20, ataxin-3-Q68 and ataxin-3-Q80 specifically interacted with GSTHHR23A, but not with GST alone (Fig. 3A). 

Phrase: "All recombinant ataxin-3-Q20,"

Phrase: "ataxin-3-Q68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin-3-Q80 specifically"

Phrase: "interacted with GSTHHR23A,"

Phrase: "but"

Phrase: "not with GST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1518422:Not [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.67: In addition, a pull-down assay was performed. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a pull-down assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.68: HHR23A also pulled down both the normal and mutant native ataxin-3 at similar levels to lymphoblastoid cell lines (Fig. 3B). 

Phrase: "HHR23A also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "pulled down both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0580846:pulled [Finding]

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant native ataxin-3 at similar levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1538301:ATAXIN 3 [Gene or Genome]
   757   C0456949:Level 3 [Intellectual Product]

Phrase: "to lymphoblastoid cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   966   C0682526:lymphoblastoid cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.69: Similar results were obtained using 293 cells or human control and MJD patient brain samples (Fig.3C). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "human control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MJD patient brain samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.70: Moreover, HHR23B also interacted with ataxin-3 in vitro (data not shown). 

Phrase: "Moreover,"

Phrase: "HHR23B also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "interacted with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.71: View larger version (43K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.72: HHR23Aataxin-3 interaction in vitro by GST pull-down assay. 

Phrase: "HHR23Aataxin-3 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "in vitro by GST pull-down assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C1515653:In Vitro Assay [Research Activity]
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.73: Bound ataxin-3 was detected using MJ2-5-3 antibody (7). 

Phrase: "Bound ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MJ2-5-3 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.74: (A) Interaction of HHR23A with recombinant ataxin-3. 

Phrase: "(A) Interaction of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with recombinant ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.75: GST or GSTHHR23A was incubated with recombinant ataxin-3-Q20, ataxin-3-Q68 and ataxin-3-Q80 expressed from pET-21(a) vectors. 

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "GSTHHR23A"

Phrase: "was"

Phrase: "incubated with recombinant ataxin-3-Q20,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1538301:ATAXIN 3 [Gene or Genome]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1514798:recombinant [Organism]

Phrase: "ataxin-3-Q68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin-3-Q80"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "expressed from pET-21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031268:Pet [Animal]

Phrase: "(a) vectors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.76: All of the normal and mutant recombinant ataxin-3 proteins interacted with GSTHHR23A, but not with GST alone. 

Phrase: "All of the normal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0444868:All [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "and"

Phrase: "mutant recombinant ataxin-3 proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   875   C0034861:Recombinant Proteins [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacted with GSTHHR23A,"

Phrase: "but"

Phrase: "not with GST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1518422:Not [Functional Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.77: Input represents 10% of ataxin-3 incubated with GST or GSTHHR23A. 

Phrase: "Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "10% of ataxin-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1538301:ATAXIN 3 [Gene or Genome]
   819   C1538308:ATAXIN 10 [Gene or Genome]
   819   C1883310:10^3 [Quantitative Concept]

Phrase: "incubated with GST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "GSTHHR23A."
Processing 00000000.tx.78: , negative control (no input protein). 

Phrase: ", negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "no input protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.79: (B) Interaction of HHR23A with native human ataxin-3 from control or patient lymphoblasts. 

Phrase: "(B) Interaction of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with native human ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "patient lymphoblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0229613:Lymphoblasts [Cell]
   861   C1167770:Lymphoblasts [Laboratory Procedure]
Processing 00000000.tx.80: GST or GSTHHR23A was incubated with the supernatant of cell lysates from lymphoblasts of one control and two MJD patients. 

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "GSTHHR23A"

Phrase: "was"

Phrase: "incubated with the supernatant of cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C1881488:Cell Lysate [Physical Object]
           Lysate
   748   C0007634:Cell [Cell]
   748   C1269647:Cell [Cell]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1550101:Supernatant [Body Substance]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "from lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0229613:Lymphoblasts [Cell]
  1000   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "of one control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "two MJD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.81: Both the normal and mutant ataxin-3 interacted with GSTHHR23A, but not with GST alone. 

Phrase: "Both"

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacted with GSTHHR23A,"

Phrase: "but"

Phrase: "not with GST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1518422:Not [Functional Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.82: Input represents 10% of total lysates used in the binding experiment. 

Phrase: "Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "10% of total lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   737   C1881488:Lysate [Physical Object]

Phrase: "used in the binding experiment."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   760   C1706386:Experiment [Conceptual Entity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.83: , negative control (no input protein). 

Phrase: ", negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "no input protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.84: (C) Interaction of HHR23A with ataxin-3 from 293 cells, human control and MJD patient brains. 

Phrase: "(C) Interaction of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "from 293 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "human control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MJD patient brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.85: The supernatant of 293 cell lysate or the supernatant of brain homogenate was incubated with GST or GSTHHR23A. 

Phrase: "The supernatant of 293 cell lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1550101:Supernatant [Body Substance]

Phrase: "or"

Phrase: "the supernatant of brain homogenate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "incubated with GST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "GSTHHR23A."
Processing 00000000.tx.86: Ataxin-3 of human brain also specifically interacts with HHR23A. 

Phrase: "Ataxin-3 of human brain also specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts with HHR23A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1419236:HHR23A [Gene or Genome]
Processing 00000000.tx.87: , negative control (no input protein).  

Phrase: ", negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "no input protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.88: Ataxin-3 interacts specifically with the UBL domain of the HHR23 proteins, but not with ubiquitin To determine which domain in the HHR23 proteins is required for interaction with ataxin-3, we generated different N- and C-terminal deletion mutants of the HHR23 proteins in vector pGEX-5x-1 (Fig. 4A). 

Phrase: "Ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts"

Phrase: "specifically with the UBL domain of the HHR23 proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0162808:Protein Domain [Spatial Concept]
   741   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not with ubiquitin To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1518422:Not [Functional Concept]

Phrase: "determine"

Phrase: "which domain in the HHR23 proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514873:Required [Functional Concept]
   790   C1704675:Interaction [Functional Concept]

Phrase: "with ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "different N-"

Phrase: "and"

Phrase: "C-terminal deletion mutants of the HHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   744   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in vector pGEX-5x-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.89: These deletion mutants of the HHR23 proteins were tested for interaction with ataxin-3 in GST pull-down assays. 

Phrase: "These deletion mutants of the HHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "tested for interaction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392366:tested [Intellectual Product]
   790   C1704675:Interaction [Functional Concept]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "in GST pull-down assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.90: Expression of these deletion mutants of GSTHHR23A and GSTHHR23B was examined using Coomassie Brilliant Blue R-250 staining of proteins separated by SDSPAGE (Fig. 4B). 

Phrase: "Expression of these deletion mutants of GSTHHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GSTHHR23B"

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Coomassie Brilliant Blue R-250 staining of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "separated by SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: The supernatants of 293 cell extracts were tested for binding with GSTHHR23 and associated deletion mutants of GST fusions coupled to glutathioneagarose beads. 

Phrase: "The supernatants of 293 cell extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for binding"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C0392366:tested [Intellectual Product]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with GSTHHR23"

Phrase: "and"

Phrase: "associated deletion mutants of GST fusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "to glutathioneagarose beads."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]
Processing 00000000.tx.92: Constructs containing the UBL domain of HHR23A and HHR23B were sufficient for strong interaction with ataxin-3; 

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the UBL domain of HHR23A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "were"

Phrase: "sufficient for strong interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.93: however, deletion of the HHR23A and HHR23B UBL domains completely abolished HHR23Aataxin-3 and HHR23Bataxin-3 interaction (Fig. 4C). 

Phrase: "however,"

Phrase: "deletion of the HHR23A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "HHR23B UBL domains completely abolished HHR23Aataxin-3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   883   C1421300:UBIQUITIN-LIKE 3 [Gene or Genome]
   793   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0205197:Completely [Qualitative Concept]
   793   C1419237:HHR23B [Gene or Genome]
   793   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   793   C3541311:HHR23B [Gene or Genome]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "HHR23Bataxin-3 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: Therefore, the UBL domain of HHR23A and HHR23B is sufficient and required for this interaction. 

Phrase: "Therefore,"

Phrase: "the UBL domain of HHR23A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "is"

Phrase: "sufficient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205410:Sufficient [Qualitative Concept]

Phrase: "and"

Phrase: "required for this interaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514873:Required [Functional Concept]
   770   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.95: View larger version (29K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.96: The UBL domain of the HHR23 proteins interacts with ataxin-3. 

Phrase: "The UBL domain of the HHR23 proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0162808:Protein Domain [Spatial Concept]
   750   C1514562:Protein Domain [Amino Acid Sequence]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "interacts with ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.97: (A)Schematic diagram of the deletion mutants of the HHR23 proteins expressed as GST fusion proteins. 

Phrase: "(A)Schematic diagram of the deletion mutants of the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0681494:Diagram [Intellectual Product]

Phrase: "expressed as GST fusion proteins."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   757   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1418948:PROTEIN S [Gene or Genome]
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.98: The gray box indicates the UBL domain and the black box indicates the XPC-binding domain. 

Phrase: "The gray box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "indicates"

Phrase: "the UBL domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the black box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "indicates"

Phrase: "the XPC-binding domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   734   C2752147:Xeroderma pigmentosum group C [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.99: (B) Expression of deletion mutants of GSTHHR23 proteins was detected using Coomassie Brilliant Blue R-250 staining. 

Phrase: "(B) Expression of deletion mutants of GSTHHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Coomassie Brilliant Blue R-250 staining."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0487602:Staining [Laboratory Procedure]
   799   C1704680:Staining [Finding]
   734   C0056271:Coomassie blue R 250 [Organic Chemical]
           Coomassie brilliant blue R
Processing 00000000.tx.100: (C) Binding of deletion mutants of the HHR23 proteins to ataxin-3. 

Phrase: "(C) Binding of deletion mutants of the HHR23 proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   762   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745 E C0033618:Protein Binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "to ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.101: GST or deletion mutants of GSTHHR23 proteins were incubated with supernatants from 293 cell lysates. 

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "deletion mutants of GSTHHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "incubated with supernatants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   756   C1550101:Supernatant [Body Substance]

Phrase: "from 293 cell lysates."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
Processing 00000000.tx.102: The deletion mutants of the HHR23 proteins containing the UBL domain interacted with ataxin-3. 

Phrase: "The deletion mutants of the HHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the UBL domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "interacted with ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.103: Input represents 10% of 293 cell lysates used in the binding experiment.  

Phrase: "Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "10% of 293 cell lysates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "used in the binding experiment."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   760   C1706386:Experiment [Conceptual Entity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.104: Since ataxin-3 interacts with the UBL domain of the HHR23 proteins, we wondered whether ataxin-3 binds to any proteins containing a homolog of ubiquitin. 

Phrase: "Since"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts with the UBL domain of the HHR23 proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0162808:Protein Domain [Spatial Concept]
   741   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "we"

Phrase: "wondered"

Phrase: "whether"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "binds to any proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a homolog of ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1334043:Homolog [Gene or Genome]
Processing 00000000.tx.105: To examine this, we produced a GSTubiquitin fusion to test for binding of ataxin-3 and ubiquitin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "this,"

Phrase: "we"

Phrase: "produced"

Phrase: "a GSTubiquitin fusion to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "test for binding of ataxin-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1538301:ATAXIN 3 [Gene or Genome]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0243122:binding [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.106: The results clearly show that ataxin-3 interacts with the UBL domain of the HHR23 proteins but not with ubiquitin (Fig. 5). 

Phrase: "The results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts with the UBL domain of the HHR23 proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0162808:Protein Domain [Spatial Concept]
   741   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not with ubiquitin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1518422:Not [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: Only under conditions of extremely high concentrations of ubiquitin, nearly 20 times more than the UBL domain of the HHR23 proteins, was an interaction between ataxin-3 and ubiquitin detected (data not shown). 

Phrase: "Only under conditions of extremely high concentrations of ubiquitin,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   742   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086045:Concentrations [Mental Process]
   742   C0205171:Only [Quantitative Concept]
   742   C0205250:High [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1720467:Only [Intellectual Product]
   742   C2700149:HIGH [Intellectual Product]
   708   C0012634:condition [Disease or Syndrome]
   708   C0348080:Condition [Qualitative Concept]
   708 E C1446561:Concentration [Quantitative Concept]
   708   C1705253:Condition [Conceptual Entity]

Phrase: "nearly 20 times more than the UBL domain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0040223:times [Temporal Concept]
   742   C1632851:Times [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]

Phrase: "of the HHR23 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "an interaction between ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: View larger version (19K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.109: Ataxin-3 specifically interacts with the UBL domain of HHR23 proteins, but not with ubiquitin. 

Phrase: "Ataxin-3 specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts with the UBL domain of HHR23 proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   784   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C0162808:Protein Domain [Spatial Concept]
   745   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not with ubiquitin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.110: (A) The proteins GST, GSTHHR23A(182), GSTHHR23B(180) and GSTubiquitin coupled to glutathioneSepharose beads was detected using Coomassie Brilliant Blue R-250 staining. 

Phrase: "(A)"

Phrase: "The proteins GST,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   858   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1418948:PROTEIN S [Gene or Genome]
   812   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "GSTHHR23A"

Phrase: "(182"

Phrase: ")"

Phrase: ","

Phrase: "GSTHHR23B"

Phrase: "(180"

Phrase: ")"

Phrase: "and"

Phrase: "GSTubiquitin"

Phrase: "coupled to glutathioneSepharose beads"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Coomassie Brilliant Blue R-250 staining."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0487602:Staining [Laboratory Procedure]
   799   C1704680:Staining [Finding]
   734   C0056271:Coomassie blue R 250 [Organic Chemical]
           Coomassie brilliant blue R
Processing 00000000.tx.111: (B) The same amounts of proteins as used in (A) were coupled to glutathioneSepharose beads and then incubated with 293 cell lysates. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The same amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "as"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in (A)"

Phrase: "were"

Phrase: "coupled to glutathioneSepharose beads"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with 293 cell lysates."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: The bound ataxin-3 was detected using MJ2-5-3 antibody. 

Phrase: "The bound ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MJ2-5-3 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.113: Input represents 10% of 293 cell lysates used in the binding experiment.  

Phrase: "Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "10% of 293 cell lysates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "used in the binding experiment."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1273517:used [Finding]
   760   C1706386:Experiment [Conceptual Entity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.114: Co-immunoprecipitation of ataxin-3 and HHR23A To further characterize the in vivo interaction of ataxin-3 and the HHR23 proteins, we co-transfected 293 cells with pEGFP-N1 vectors expressing EGFP or HHR23AEGFP and pREP10-MJD vectors expressing ataxin-Q20 or ataxin-Q80. 

Phrase: "Co-immunoprecipitation of ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "HHR23A To further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1419236:HHR23A [Gene or Genome]

Phrase: "characterize"

Phrase: "the in vivo interaction of ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the HHR23 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "co-transfected"

Phrase: "293 cells with pEGFP-N1 vectors"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "EGFP"

Phrase: "or"

Phrase: "HHR23AEGFP"

Phrase: "and"

Phrase: "pREP10-MJD vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0012656:Disease Vectors [Animal]
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "ataxin-Q20"

Phrase: "or"

Phrase: "ataxin-Q80."
Processing 00000000.tx.115: When HHR23AEGFP was immunoprecipitated from the supernatants of cell lysates with anti-GFP antibody, co-transfected ataxin-3 was co-immunoprecipitated (Fig. 6). 

Phrase: "When"

Phrase: "HHR23AEGFP"

Phrase: "was"

Phrase: "immunoprecipitated from the supernatants of cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C1881488:Cell Lysate [Physical Object]
           Lysate
   748   C0007634:Cell [Cell]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
   714   C1550101:Supernatant [Body Substance]

Phrase: "with anti-GFP antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-transfected"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: However, no ataxin-3 was co-immunoprecipitated by anti-GFP antibody in 293 cells co-transfected with vectors expressing EGFP and ataxin-3 (Fig. 6). 

Phrase: "However,"

Phrase: "no ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "co-immunoprecipitated by anti-GFP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "in 293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "EGFP"

Phrase: "and"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.117: These results suggest that both the normal and mutant ataxin-3 specifically interact with HHR23A in vivo. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3 specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interact with HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1419236:HHR23A [Gene or Genome]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.118: View larger version (26K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.119: HHR23A interaction with ataxin-3 in vivo by co-immunoprecipitation analysis. 

Phrase: "HHR23A interaction with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "in vivo by co-immunoprecipitation analysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.120: 293 cells co-transfected with EGFP or HHR23AEGFP and ataxin-3-20Q or ataxin-3-80Q were collected 48 h after transfection. 

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with EGFP"

Phrase: "or"

Phrase: "HHR23AEGFP"

Phrase: "and"

Phrase: "ataxin-3-20Q"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521048:20q [Nucleotide Sequence]
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "or"

Phrase: "ataxin-3-80Q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "48 h after transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.121: The supernatants of cell lysates were immunoprecipitated with anti-GFP antibody. 

Phrase: "The supernatants of cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "immunoprecipitated with anti-GFP antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.122: Immunoprecipitates were subjected to immunoblot analysis using MJ2-5-3 antibody. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MJ2-5-3 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.123: Ataxin-3 was co-immunoprecipitated by anti-GFP antibody in 293 cells co-transfected with vectors expressing HHR23AEGFP and ataxin-3, but not co-immunoprecipitated in cells expressing EGFP and ataxin-3.  

Phrase: "Ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "co-immunoprecipitated by anti-GFP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "in 293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "HHR23AEGFP"

Phrase: "and"

Phrase: "ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "co-immunoprecipitated in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "EGFP"

Phrase: "and"

Phrase: "ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.124: HHR23A co-localizes with ataxin-3 and its mutant aggregates Since the HHR23 proteins interacted with ataxin-3 in vitro and in vivo, we further examined the intracellular localization of these proteins. 

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "co-localizes with ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0392752:localize [Spatial Concept]

Phrase: "and"

Phrase: "its mutant aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "Since"

Phrase: "the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacted with ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the intracellular localization of these proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1660749:intracellular localization [Cell Function]
   767   C0597704:protein localisation [Cell Function]
   767   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.125: Vectors expressing EGFP, ataxin-3-Q20 EGFP, ataxin-3-Q80EGFP and ataxin-3-Q130EGFP were transfected into 293 cells. 

Phrase: "Vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "EGFP,"

Phrase: "ataxin-3-Q20 EGFP,"

Phrase: "ataxin-3-Q80EGFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin-3-Q130EGFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "were"

Phrase: "transfected into 293 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: Ataxin-3-Q20EGFP and ataxin-3-Q80EGFP showed a ubiquitous localization in transfected cells, being stronger in the nuclei (Fig. 7B and C). 

Phrase: "Ataxin-3-Q20EGFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin-3-Q80EGFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a ubiquitous localization in transfected cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1660153:cell localization [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "being"

Phrase: "stronger in the nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0442821:Strong [Qualitative Concept]

Phrase: "(Fig. 7B"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.127: Nuclear aggregates formed by ataxin-3-Q130 were observed and the diffusely distributed ataxin-3-Q130 appeared to fade from the nucleus after formation of intranuclear inclusions (Fig. 7D). 

Phrase: "Nuclear aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0544908:Nuclear aggregate [Cell or Molecular Dysfunction]
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "formed by ataxin-3-Q130"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205431:Formed [Functional Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "the diffusely distributed ataxin-3-Q130"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fade from the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "after formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of intranuclear inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1366904:Intranuclear Inclusions [Cell Component]
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 7D"

Phrase: ")."
Processing 00000000.tx.128: The HHR23 proteins have been shown previously to have a clear nuclear localization and appeared to be absent from nucleoli (16). 

Phrase: "The HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously to"

Phrase: "have"

Phrase: "a clear nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "absent from nucleoli"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.129: Our results also showed HHR23A to be localized diffusely in the nucleus with the exception of the nucleoli, bearing a similar cellular localization to ataxin-3 (Fig. 7E). 

Phrase: "Our results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "HHR23A to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "be"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "diffusely in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of the nucleoli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007609:Nucleolus [Cell Component]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a similar cellular localization to ataxin-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1660642:cellular localisation [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "(Fig. 7E"

Phrase: ")."
Processing 00000000.tx.130: In293 cells co-transfected with ataxin-3EGFP and HHR23Av5, these two proteins were observed to be co-localized (Fig. 8). 

Phrase: "In293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with ataxin-3EGFP"

Phrase: "and"

Phrase: "HHR23Av5,"

Phrase: "these two proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "co-localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:Localized [Spatial Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.131: Moreover, when the mutant ataxin-3 formed aggregates in the nucleus, the diffuse nuclear distribution of HHR23A was also abolished and HHR23A co-localized with the aggregates of mutant ataxin-3 (Fig. 8). 

Phrase: "Moreover,"

Phrase: "when"

Phrase: "the mutant ataxin-3 formed aggregates in the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205418:aggregates [Qualitative Concept]

Phrase: "the diffuse nuclear distribution of HHR23A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "abolished"

Phrase: "and"

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "co-localized with the aggregates of mutant ataxin-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1538301:ATAXIN 3 [Gene or Genome]
   742   C0205418:aggregates [Qualitative Concept]
   742   C0392752:Localized [Spatial Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.132: Seventeen percent of aggregates formed by mutant ataxin-3 showed co-localization with HHR23A (data from three transfections). 

Phrase: "Seventeen percent of aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "formed by mutant ataxin-3"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205431:Formed [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "co-localization with HHR23A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "(data from three transfections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.133: View larger version (15K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.134: Localization of ataxin-3 and HHR23A overexpressed in 293 cells. 

Phrase: "Localization of ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "overexpressed in 293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1514559:overexpress [Genetic Function]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: 293 cells were transfected with vectors pEGFP-N1 (A), pEGFP-N1-MJD20Q (B), pEGFP-N1-MJD80Q (C), pEGFP-N1-MJD130Q (D) and pcDNA3.1/His-v5-HHR23A (E). 

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with vectors pEGFP-N1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441962:N1 [Finding]
   760   C0442335:Vectors [Spatial Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "pEGFP-N1-MJD20Q"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "pEGFP-N1-MJD80Q"

Phrase: "(C), pEGFP-N1-MJD130Q"

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "pcDNA3.1/"

Phrase: "His-v5-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.136: After 48 h, the transfected cells were observed using an inverted microscope IX70 (Olympus). 

Phrase: "After 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an inverted microscope IX70"

Phrase: "(Olympus"

Phrase: ")."
Processing 00000000.tx.137: Cells expressing normal or mutant ataxin-3EGFP showed cytoplasmic and stronger nuclear fluorescence (arrowhead) (B and C). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "mutant ataxin-3EGFP"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "stronger nuclear fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.138: The diffuse fluorescence in the nucleus was abolished after the formation of intranuclear aggregates in cells expressing ataxin-3-Q130EGFP (arrow) (D). 

Phrase: "The diffuse fluorescence in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "abolished after the formation of intranuclear aggregates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205418:aggregates [Qualitative Concept]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "ataxin-3-Q130EGFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.139: 293 cells transfected with pcDNA3.1/His-v5-HHR23A were detected with anti-v5 antibody 48 h after transfection. 

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pcDNA3.1/"

Phrase: "His-v5-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "were"

Phrase: "detected with anti-v5 antibody 48 h"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0221137:Anti H [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0369286:H not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0441932:H+ [Classification]
   748   C0442726:Detected [Finding]
   748   C0564385:/h [Quantitative Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.140: HHR23A-expressing cells showed a stronger fluorescence in the nucleus, but weaker fluorescence in the nucleoli and cytosol (E). 

Phrase: "HHR23A-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a stronger fluorescence in the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "weaker fluorescence in the nucleoli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.141: Bar, 20 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.142: View larger version (18K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.143: Recruitment of HHR23A to aggregates formed by mutant ataxin-3. 

Phrase: "Recruitment of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2949735:Recruitment [Activity]

Phrase: "to aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "formed by mutant ataxin-3."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205431:Formed [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.144: 293 cells were co-transfected with vectors expressing ataxin-3EGFP (green) and HHR23Av5. 

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "expressing"

Phrase: "ataxin-3EGFP"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "HHR23Av5."
Processing 00000000.tx.145: Cy3-labeled anti-v5 antibodies were used to detect HHR23v5 (red). 

Phrase: "Cy3-labeled anti-v5 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "HHR23v5"

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.146: Cells were observed using confocal microscopy. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "confocal microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.147: Co-localization of ataxin-3 and HHR23A is illustrated. 

Phrase: "Co-localization of ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "is"

Phrase: "illustrated."
Processing 00000000.tx.148: The strong red signal also overlaps with a green aggregate, indicating the presence of HHR23A in the aggregates caused by mutant ataxin-3. 

Phrase: "The strong red signal also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "overlaps with a green aggregate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185027:overlap [Therapeutic or Preventive Procedure]
   760   C0205418:Aggregate [Qualitative Concept]
   760   C0332583:Green [Qualitative Concept]
   760   C1948020:Overlap [Conceptual Entity]

Phrase: "indicating"

Phrase: "the presence of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "caused by mutant ataxin-3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.149: Bar, 20 m.   

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.150: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Using the two-hybrid system to screen for ataxin-3-binding protein(s), we have identified two ataxin-3-interacting proteins, namely HHR23A and HHR23B, which are human homologs of the yeast DNA repair protein RAD23. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the two-hybrid system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "screen for ataxin-3-binding protein"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   820   C0443625:Binding protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1538301:ATAXIN 3 [Gene or Genome]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220908:screen [Health Care Activity]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two ataxin-3-interacting proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "namely HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "human homologs of the yeast DNA repair protein RAD23."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   708   C1334043:Homolog [Gene or Genome]
Processing 00000000.tx.151: The interaction of ataxin-3 with the HHR23 proteins is highly specific and has been verified using several methods for detecting proteinprotein interactions. 

Phrase: "The interaction of ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "highly specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several methods for detecting proteinprotein interactions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.152: To date, several proteins that interact with polyglutamine tract-containing disease gene products have been identified: huntingtin-associated protein (HAP1) (17), huntingtin-interacting protein (HIP1) (18) and SH3GL3, a protein containing an SH3 domain (19), interacting with huntingtin; 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "interact with polyglutamine tract-containing disease gene products"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332256:Containing [Functional Concept]
   744   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   744   C1185740:Tract [Body Part, Organ, or Organ Component]
   744   C1514468:Products [Entity]
   744   C2700400:Containing [Activity]
   743   C1416989:MAL gene [Gene or Genome]
   737   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ":"

Phrase: "huntingtin-associated protein (HAP1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "huntingtin-interacting protein (HIP1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "SH3GL3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420027:SH3GL3 [Gene or Genome]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an SH3 domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0282535:SH3 Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "interacting with huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.153: IRSp53, a human homolog of the insulin receptor tyrosine kinase substrate protein of 53 kDa (20) and the atrophin-1-interacting proteins (AIPs), which contain a WW domain (21), interacting with atrophin-1; 

Phrase: "IRSp53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332378:IRSP53 [Gene or Genome]
  1000   C1706874:IRSP53 [Gene or Genome]

Phrase: "a human homolog of the insulin receptor tyrosine kinase substrate protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   738   C1334043:Homolog [Gene or Genome]

Phrase: "of 53 kDa (20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the atrophin-1-interacting proteins (AIPs),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1861696:WW [Disease or Syndrome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "interacting with atrophin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0380757:atrophin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1540211:ATROPHIN 1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.154: cerebellar leucine-rich acidic nuclear protein (LANP), interacting with ataxin-1 (22). 

Phrase: "cerebellar leucine-rich acidic nuclear protein (LANP),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   947   C1421894:LEUCINE-RICH ACIDIC NUCLEAR PROTEIN [Gene or Genome]
   827   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0521447:Nuclear [Spatial Concept]

Phrase: "interacting with ataxin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.155: To some extent, these interacting proteins imply some function of their interacting polyglutamine tract disease gene products. 

Phrase: "To some extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "these interacting proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "imply"

Phrase: "some function of their interacting polyglutamine tract disease gene products."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0314627:Gene function [Genetic Function]
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
Processing 00000000.tx.156: However, to date, ataxin-3 is a protein of unknown function. 

Phrase: "However,"

Phrase: "to date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "is"

Phrase: "a protein of unknown function."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0815043:function protein [Amino Acid, Peptide, or Protein]
   797   C1527118:Protein Function [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.157: The present study is the first to identify ataxin-3-interacting proteins, namely the HHR23 proteins. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "identify"

Phrase: "ataxin-3-interacting proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "namely"

Phrase: "the HHR23 proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.158: RAD23 is one of the yeast proteins involved in nucleotide excision repair (NER), bearing an N-terminal UBL domain that is required for NER (23). 

Phrase: "RAD23"

Phrase: "is"

Phrase: "one of the yeast proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "involved in nucleotide excision repair (NER),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0524550:Nucleotide Excision Repair [Genetic Function]
   862   C2984260:Nucleotide excision repair [Functional Concept]
   806   C0015249:Excision Repair [Genetic Function]
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]
   760   C1314939:Involved [Functional Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "an N-terminal UBL domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "required for NER"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0524550:Nucleotide Excision Repair [Genetic Function]
   862   C2984260:Nucleotide excision repair [Functional Concept]
   806   C0015249:Excision Repair [Genetic Function]
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.159: In humans there are two homologs of yeast RAD23, HHR23A and HHR23B (14). 

Phrase: "In humans there"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "are"

Phrase: "two homologs of yeast RAD23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1334043:Homolog [Gene or Genome]

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.160: Both have an XPC-binding domain and a UBL domain. 

Phrase: "Both"

Phrase: "have"

Phrase: "an XPC-binding domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   734   C2752147:Xeroderma pigmentosum group C [Congenital Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "a UBL domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.161: The HHR23 proteins execute DNA repair through interaction with XPC (24). 

Phrase: "The HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "execute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705848:Execute [Activity]
  1000   C3245498:execute [Functional Concept]

Phrase: "DNA repair through interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0012899:DNA Repair [Genetic Function]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0043240:Repair, NOS [Organism Function]
   770   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "with XPC"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C2752147:Xeroderma pigmentosum group C [Congenital Abnormality,Disease or Syndrome]
   861   C0043346:Xeroderma Pigmentosum [Congenital Abnormality]
   861   C0441837:Group C [Classification]
   812   C0043345:Xeroderma [Disease or Syndrome]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.162: Furthermore, only a small fraction of HHR23B complexed with XPC is necessary for NER and there is excess endogenous HHR23B protein in vivo (16,25). 

Phrase: "Furthermore,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small fraction of HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "complexed with XPC"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C2752147:Xeroderma pigmentosum group C [Congenital Abnormality,Disease or Syndrome]
   790   C0043346:Xeroderma Pigmentosum [Congenital Abnormality]
   790   C0441837:Group C [Classification]
   753   C0043345:Xeroderma [Disease or Syndrome]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   719   C0439855:Complex [Qualitative Concept]
   719   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "necessary for NER"

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "excess endogenous HHR23B protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(16,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.163: Thus, HHR23B is believed to have additional functions to NER in vivo (16,25). 

Phrase: "Thus,"

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "additional functions to NER"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(16,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.164: The subcellular localization of the HHR23 proteins is primarily nuclear (16) and, in our results and several other studies, the immunoreactivity of ataxin-3 is also stronger in the nucleus (8,9). 

Phrase: "The subcellular localization of the HHR23 proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0597704:protein localisation [Cell Function]
   757   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "primarily nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "in our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "and"

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "the immunoreactivity of ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "is"

Phrase: "also stronger in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0442821:Strong [Qualitative Concept]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.165: The similarity in subcellular localization of ataxin-3 and the HHR23 proteins suggests that these proteins interact physiologically and that the biological function of ataxin-3 may be related to this interaction. 

Phrase: "The similarity in subcellular localization of ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact"

Phrase: "physiologically"

Phrase: "and"

Phrase: "that"

Phrase: "the biological function of ataxin-3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031845:Biological function, NOS [Physiologic Function]
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0031843:function [Physiologic Function]
   753   C0205460:biological [Qualitative Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "related to this interaction."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1704675:Interaction [Functional Concept]
   737 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.166: Moreover, we found no difference in the ability of the HHR23 proteins to interact with both normal and mutant ataxin-3. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in the ability of the HHR23 proteins to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "interact with both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant ataxin-3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.167: We also found that the N-terminus of ataxin-3, which does not contain a polyglutamine tract, interacts with the HHR23 proteins. 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the N-terminus of ataxin-3,"

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a polyglutamine tract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "interacts with the HHR23 proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.168: These results suggest that these interactions are most likely associated with some normal function(s) of ataxin-3. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "associated with some normal function"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C1292719:Associated function [Functional Concept]
   760   C0031843:function [Physiologic Function]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "("

Phrase: "s) of ataxin-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1538301:ATAXIN 3 [Gene or Genome]
   770   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.169: Although aside from NER the functions of the HHR23 proteins are unclear, their subcellular distribution is homogeneous localization in the nucleus but absence from the nucleoli (16). 

Phrase: "Although aside from NER"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0524550:Nucleotide Excision Repair [Genetic Function]
   833   C2984260:Nucleotide excision repair [Functional Concept]
   790   C0015249:Excision Repair [Genetic Function]
   753   C0015252:excision [Therapeutic or Preventive Procedure]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0043240:Repair, NOS [Organism Function]
   753   C0374711:Repair [Therapeutic or Preventive Procedure]
   753   C0728940:Excision [Therapeutic or Preventive Procedure]

Phrase: "the functions of the HHR23 proteins"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   783   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   753   C0542341:Functions [Functional Concept]
   750 E C1527118:Protein Function [Molecular Function]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "unclear,"

Phrase: "their subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "is"

Phrase: "homogeneous localization in the nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1659087:nucleus localisation [Biologic Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "but"

Phrase: "absence from the nucleoli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.170: In the present study we also showed that overexpressed HHR23A is localized in the nucleus. 

Phrase: "In the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that overexpressed HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "is"

Phrase: "localized in the nucleus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.171: However, cells co-transfected with HHR23A and ataxin-3-Q130 demonstrated an altered distribution pattern of HHR23A, with abolition of the homogeneous distribution and co-localization with the aggregates formed by ataxin-3-Q130. 

Phrase: "However,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "ataxin-3-Q130"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "demonstrated"

Phrase: "an altered distribution pattern of HHR23A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449775:Distribution pattern [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "with abolition"

Phrase: "of the homogeneous distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "co-localization with the aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "formed by ataxin-3-Q130."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205431:Formed [Functional Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.172: These results are similar to the phenomena observed in SCA1, namely that LANP, which by itself does not form nuclear aggregates, is recruited to subnuclear structures through its interaction with ataxin-1 (21). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "similar to the phenomena"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "observed in SCA1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0291573:SCA-1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0752120:SCA1 [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]

Phrase: "namely"

Phrase: "that LANP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1421894:LEUCINE-RICH ACIDIC NUCLEAR PROTEIN [Gene or Genome]
   840   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0521447:Nuclear [Spatial Concept]

Phrase: "which by itself"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "nuclear aggregates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0544908:Nuclear aggregate [Cell or Molecular Dysfunction]
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "is"

Phrase: "recruited to subnuclear structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]

Phrase: "through its interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with ataxin-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.173: We also co-transfected a C-terminal fragment of mutant ataxin-3, encoding amino acids 249341 and containing 130 glutamines, and HHR23A into N2a and 293 cells. 

Phrase: "We also"

Phrase: "co-transfected"

Phrase: "a C-terminal fragment of mutant ataxin-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 249341"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "containing 130 glutamines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "HHR23A into N2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "293 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.174: Surprisingly, HHR23A was also recruited to the aggregates formed by this fragment in these cell lines (data not shown). 

Phrase: "Surprisingly,"

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "recruited to the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205418:aggregates [Qualitative Concept]

Phrase: "formed by this fragment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205431:Formed [Functional Concept]
   770   C0332255:fragment [Functional Concept]
   770   C1708096:Fragment [Qualitative Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "in these cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: It has been reported that a deletion mutant form of ataxin-3 that encodes the N-terminal 80% of the ataxin-3 polypepetide without a polyglutamine tract co-localized to the inclusions formed by a C-terminal fragment of ataxin-3 containing 78 glutamine repeats, suggesting that N-terminal regions of ataxin-3 may interact with the C-terminus of the protein where the glutamine repeats reside (12). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "a deletion mutant form of ataxin-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the N-terminal 80% of the ataxin-3 polypepetide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1538301:ATAXIN 3 [Gene or Genome]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "without a polyglutamine tract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "co-localized to the inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392752:Localized [Spatial Concept]
   726   C1512693:Inclusion [Qualitative Concept]

Phrase: "formed by a C-terminal fragment of ataxin-3"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C1538301:ATAXIN 3 [Gene or Genome]
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0205088:Terminal [Temporal Concept]
   742   C0205431:Formed [Functional Concept]
   742   C0332255:fragment [Functional Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1708096:Fragment [Qualitative Concept]
   708 E C0348078:Form [Qualitative Concept]
   708 E C0376315:Form [Manufactured Object]
   708 E C1522492:Form [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "78 glutamine repeats,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that N-terminal regions of ataxin-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "may"

Phrase: "interact with the C-terminus of the protein where"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the glutamine repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "reside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.176: Considering this report and our results on the interaction domain of ataxin-3, we suggest that recruitment of the HHR23 proteins may be due to recruited endogenous full-length ataxin-3. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "our results on the interaction domain of ataxin-3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that recruitment of the HHR23 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1158950:protein recruitment [Cell Function]
   753   C2949735:Recruitment [Activity]

Phrase: "may"

Phrase: "be due to recruited endogenous full-length ataxin-3."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0678226:Due to [Functional Concept]
           due
   764   C1538301:ATAXIN 3 [Gene or Genome]
   742   C0205227:Endogenous [Functional Concept]
   742   C0443225:Full [Qualitative Concept]
   742   C1444754:Length [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]
Processing 00000000.tx.177: Furthermore, when we co-transfected HHR23Av5 and mutant truncated N-terminal huntingtin (tNhtt) with EGFP into 293 cells, HHR23A failed to be recruited to the aggregates formed by mutant tNhtt (data not shown). 

Phrase: "Furthermore,"

Phrase: "when"

Phrase: "we"

Phrase: "co-transfected"

Phrase: "HHR23Av5"

Phrase: "and"

Phrase: "mutant truncated N-terminal huntingtin (tNhtt) with EGFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1415504:HUNTINGTIN [Gene or Genome]

Phrase: "into 293 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "recruited to the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205418:aggregates [Qualitative Concept]

Phrase: "formed by mutant tNhtt"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0205088:Terminal [Temporal Concept]
   760   C0205431:Formed [Functional Concept]
   760   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1415504:HUNTINGTIN [Gene or Genome]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: When we transfected HHR23Av5 into an N2a stable inducible cell line (26), which expresses tNhtt-Q150EGFP after induction with muristerone A, no HHR23A co-localized with the aggregates formed by tNhtt-Q150 (data not shown). 

Phrase: "When"

Phrase: "we"

Phrase: "transfected"

Phrase: "HHR23Av5 into an N2a stable inducible cell line"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "expresses"

Phrase: "tNhtt-Q150EGFP after induction"

Phrase: "with muristerone A,"

Phrase: "no HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "co-localized with the aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205418:aggregates [Qualitative Concept]
   760   C0392752:Localized [Spatial Concept]

Phrase: "formed by tNhtt-Q150"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0205088:Terminal [Temporal Concept]
   760   C0205431:Formed [Functional Concept]
   760   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1415504:HUNTINGTIN [Gene or Genome]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.179: These results suggest that the HHR23 proteins specifically interact with ataxin-3, but not with any polyglutamine tracts. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the HHR23 proteins specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact with ataxin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "but"

Phrase: "not with any polyglutamine tracts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   760   C1185740:tracts [Body Part, Organ, or Organ Component]
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.180: The HHR23 proteins have also been implicated in other processes, such as involvement in the proteolytic pathway in cells (27) and regulation of cell cycle progression (28,29). 

Phrase: "The HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "implicated in other processes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "such as involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involvement [Functional Concept]

Phrase: "in the proteolytic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(27"

Phrase: ")"

Phrase: "and"

Phrase: "regulation of cell cycle progression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155872:regulation of cell cycle progression [Cell Function]
           regulation of cell cycle
           Cell Cycle Regulation
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.181: Although no difference in the ability of HHR23A to bind to normal or mutant ataxin-3 was observed, the recruitment of HHR23A to the aggregates formed by mutant ataxin-3 may affect any of the aforementioned functions of the HHR23 proteins. 

Phrase: "Although"

Phrase: "no difference in the ability of HHR23A to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "bind to normal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "mutant ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "the recruitment of HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2949735:Recruitment [Activity]

Phrase: "to the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "formed by mutant ataxin-3"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205431:Formed [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "any of the aforementioned functions of the HHR23 proteins."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   762   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0542341:Functions [Functional Concept]
   742   C1552551:Any [Qualitative Concept]
   742   C3272371:ANY [Intellectual Product]
   728 E C1527118:Protein Function [Molecular Function]
   708 E C0031843:function [Physiologic Function]
   708 E C0700205:FUNCTION [Classification]
   708 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.182: The UBL domain of RAD23 is important for NER function (22) and deletion of this domain impairs NER. 

Phrase: "The UBL domain of RAD23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "important for NER function"

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "deletion of this domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "impairs"

Phrase: "NER."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0524550:Nucleotide Excision Repair [Genetic Function]
  1000   C2984260:Nucleotide excision repair [Functional Concept]
   901   C0015249:Excision Repair [Genetic Function]
   827   C0015252:excision [Therapeutic or Preventive Procedure]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0043240:Repair, NOS [Organism Function]
   827   C0374711:Repair [Therapeutic or Preventive Procedure]
   827   C0728940:Excision [Therapeutic or Preventive Procedure]
Processing 00000000.tx.183: Recently, RAD23 has been shown to interact with yeast 26S proteasomes through its UBL domain (27,30). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "RAD23"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with yeast 26S proteasomes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1166804:26S proteasome [Cell Component]
   760   C0036025:yeast [Fungus]
   760   C0043392:Yeast [Food]
   760   C0043393:Yeast [Fungus]
   760   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   760   C1552140:26s [Body Part, Organ, or Organ Component]
   726 E C1325620:proteasome [Cell Component]
   726 E C1752727:Proteasome [Molecular Function]

Phrase: "through its UBL domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(27,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.184: The activity of ATPase in the 19S regulatory complex of the proteasome is required for NER and mutations in a 19S regulatory complex ATPase can result in increased UV sensitivity (31). 

Phrase: "The activity of ATPase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1148926:ATPase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "in the 19S regulatory complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "of the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "required for NER"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0524550:Nucleotide Excision Repair [Genetic Function]
   862   C2984260:Nucleotide excision repair [Functional Concept]
   806   C0015249:Excision Repair [Genetic Function]
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "mutations in a 19S regulatory complex ATPase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "result in increased UV sensitivity"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   797   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0205217:Increased [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1961129:uV [Quantitative Concept]
   760   C2349185:Sensitivity [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: These results suggest that the interaction between proteasomes and the UBL domain of RAD23 is associated with NER. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the interaction between proteasomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1514525:Proteasome Interaction [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the UBL domain of RAD23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "associated with NER."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0524550:Nucleotide Excision Repair [Genetic Function]
   862   C2984260:Nucleotide excision repair [Functional Concept]
   806   C0015249:Excision Repair [Genetic Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.186: Furthermore, the two human homologs of RAD23, the HHR23 proteins, interact with the S5a subunit of the 26S proteasome directly through their UBL domains (27). 

Phrase: "Furthermore,"

Phrase: "the two human homologs of RAD23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1334043:Homolog [Gene or Genome]

Phrase: "the HHR23 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact with the S5a subunit of the 26S proteasome directly"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1166804:26S proteasome [Cell Component]
   739   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1325620:proteasome [Cell Component]
   739   C1419034:S5A [Gene or Genome]
   739   C1552140:26s [Body Part, Organ, or Organ Component]
   739   C1711351:Subunit [Quantitative Concept]
   739   C1752727:Proteasome [Molecular Function]
   739   C1947931:Directly [Qualitative Concept]

Phrase: "through their UBL domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.187: HHR23B interacts with the 26S proteasome in HeLa cell extracts and has an inhibitory effect on the degradation of [125I]lysozyme in rabbit reticulocyte lysate, suggesting that part of the HHR23 proteins is involved in the proteolytic pathway in cells (27). 

Phrase: "HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "interacts with the 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1166804:26S proteasome [Cell Component]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1552140:26s [Body Part, Organ, or Organ Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "in HeLa cell extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]
   734   C0018873:HeLa cell [Cell]

Phrase: "and"

Phrase: "has"

Phrase: "an inhibitory effect on the degradation of [125I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "]lysozyme in rabbit reticulocyte lysate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
   760   C1416945:LYSOZYME [Gene or Genome]
   760   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that part of the HHR23 proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "is"

Phrase: "involved in the proteolytic pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0597304:Proteolytic [Molecular Function]
   760   C1314939:Involved [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   760   C1947941:proteolytic [Enzyme]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.188: Our results revealed that ataxin-3 interacts specifically with the UBL domain of the HHR23 proteins, but not with ubiquitin. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "interacts"

Phrase: "specifically with the UBL domain of the HHR23 proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C0949455:Ubiquitin-Like Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0162808:Protein Domain [Spatial Concept]
   741   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not with ubiquitin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.189: Therefore, ataxin-3 may also be involved in NER or the proteolytic pathway through physiologically and functionally interacting with the UBL domain of HHR23. 

Phrase: "Therefore,"

Phrase: "ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "involved in NER"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0524550:Nucleotide Excision Repair [Genetic Function]
   862   C2984260:Nucleotide excision repair [Functional Concept]
   806   C0015249:Excision Repair [Genetic Function]
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]
   760   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "the proteolytic pathway through physiologically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "functionally"

Phrase: "interacting with the UBL domain of HHR23."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.190: Another possibility is that this interaction increases the susceptibility of neurons to the degeneration caused by mutant ataxin-3, through the interaction of the HHR23 proteins with the 26S proteasome, which subsequently affects the proteolytic pathway in certain neurons, although our studies have not yet addressed this possibility. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the susceptibility of neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to the degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "caused by mutant ataxin-3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "through the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "of the HHR23 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with the 26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "which subsequently"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the proteolytic pathway in certain neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "although"

Phrase: "our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "this possibility."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.191: Future research will focus on determining the potential relationship between ataxin-3 and the function(s) of the HHR23 proteins.  

Phrase: "Future research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "will"

Phrase: "focus on determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205234:Focus [Spatial Concept]
   790   C1285542:focus [Functional Concept]

Phrase: "the potential relationship between ataxin-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "s) of the HHR23 proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1418948:PROTEIN S [Gene or Genome]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.192: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Plasmid constructs The normal MJD1 gene (3) containing 20 CAG repeats was inserted into the BamHI and SalI sites of pGEX-5x-1 (Amersham Pharmacia Biotech, Uppsala, Sweden) (7). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "The normal MJD1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "was"

Phrase: "inserted into the BamHI"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0441587:Inserted [Health Care Activity]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "SalI sites of pGEX-5x-1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.193: The mutant MJD1 gene was created by RTPCR using the primers MJD1956F and MJD2877R (Table 1) and mRNA which had been extracted from the brains of MJD patients. 

Phrase: "The mutant MJD1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0678941:mutant gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "created by RTPCR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1707531:Created By [Qualitative Concept]
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primers MJD1956F"

Phrase: "and"

Phrase: "MJD2877R"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "extracted from the brains of MJD patients."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0006111:Disease of brain, NOS [Disease or Syndrome]
           Brain Disease
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C3541890:EXTRACTED [Finding]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]
   711 E C2828366:Extract [Substance]
Processing 00000000.tx.194: BglIIStuI fragments of MJD1 containing 68 or 80 CAG repeats were excised from the PCR products and exchanged with normal MJD1 in pGEX-5x-1. 

Phrase: "BglIIStuI"

Phrase: "fragments of MJD1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1538301:MJD1 [Gene or Genome]
   790   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "or"

Phrase: "80 CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "were"

Phrase: "excised from the PCR products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "exchanged with normal MJD1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1538301:MJD1 [Gene or Genome]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0678640:exchange [Social Behavior]

Phrase: "in pGEX-5x-1."
Processing 00000000.tx.195: Full-length MJD1 constructs containing 20, 68 or 80 CAG repeats were excised from the pGEX-5x-1 vector and subcloned into the GAL4-BD vector pAS2-1 via BamHI and SalI sites to generate the plasmids pAS2-1-MJD-CAG20, pAS2-1-MJD-CAG68 and pAS2-1-MJD-CAG80. 

Phrase: "Full-length MJD1 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "or"

Phrase: "80 CAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]

Phrase: "were"

Phrase: "excised from the pGEX-5x-1 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "subcloned into the GAL4-BD vector pAS2-1"

Phrase: "via BamHI"

Phrase: "and"

Phrase: "SalI sites to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "generate"

Phrase: "the plasmids pAS2-1-MJD-CAG20,"

Phrase: "pAS2-1-MJD-CAG68"

Phrase: "and"

Phrase: "pAS2-1-MJD-CAG80."
Processing 00000000.tx.196: A human fetal brain cDNA library was then constructed in the GAL4-activation domain (GAL4-AD) vector pACT2 (Clontech, Palo Alto, CA). 

Phrase: "A human fetal brain cDNA library"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0440731:Fetal brain [Embryonic Structure]
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0015965:Fetal [Embryonic Structure]
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0521457:Fetal [Functional Concept]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "constructed in the GAL4-activation domain (GAL4-AD) vector pACT2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442335:Vector [Spatial Concept]
   744   C1416832:GAL4 [Gene or Genome]
   744   C1705099:Vector [Idea or Concept]
   744   C1879547:Activation [Activity]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
   711   C2827421:Construct [Classification]

Phrase: "(Clontech,"

Phrase: "Palo Alto,"

Phrase: "CA)."
Processing 00000000.tx.197: The pACT2-HHR23A gene was obtained from a two-hybrid screen. 

Phrase: "The pACT2-HHR23A gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "obtained from a two-hybrid screen."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0599647:Two Hybrid [Molecular Biology Research Technique]
   753   C0020205:Hybrid [Organism]
   753   C0205448:Two [Quantitative Concept]
   753   C0220908:screen [Health Care Activity]
   753   C1301820:Obtained [Functional Concept]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.198: The HHR23B gene was obtained by PCR using primers w16 and w17 from a human fetal spleen cDNA library (Stratagene, La Jolla, CA) and pACT2-HHR23B was created by subcloning the PCR product into the pACT2 vector at the BamHI and XhoI sites. 

Phrase: "The HHR23B gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w16"

Phrase: "and"

Phrase: "w17 from a human fetal spleen cDNA library"

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "pACT2-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "was"

Phrase: "created by subcloning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the PCR product into the pACT2 vector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "at the BamHI"

Phrase: "and"

Phrase: "XhoI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.199: pAS2-1-MJD(1531), which encodes a fusion of the N-terminus of ataxin-3 (amino acids 1177) was created by digesting pAS2-1-MJD-20Q with PstI to remove the C-terminus of MJD1 and ligating the vector again. 

Phrase: "pAS2-1-MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(1531"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a fusion of the N-terminus of ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(amino acids 1177"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "created by digesting pAS2-1-MJD-20Q"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C1707531:Created By [Qualitative Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0868946:digesting [Physiologic Function]
   744   C1521048:20q [Nucleotide Sequence]
   744   C1706214:Created [Activity]
   739   C1425075:MALS-1 [Gene or Genome]
   711 E C3244320:create [Functional Concept]

Phrase: "with PstI to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the C-terminus of MJD1"

Phrase: "and"

Phrase: "ligating"

Phrase: "the vector again."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.200: To create the constructs pAS2-1-MJD399747, which encodes a fusion of the middle fragment of ataxin-3 (amino acids 133249), and pAS2-1-MJD3991071, which encodes a fusion of the C-terminus of ataxin-3 (amino acids 133357), we cut out the fragment of MJD1 gene from pAS2-1-MJD-20Q with EcoRI and SalI and subcloned this fragment into pBluescript II SK(+). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "the constructs pAS2-1-MJD399747,"

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a fusion of the middle fragment of ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(amino acids 133249"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pAS2-1-MJD3991071,"

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a fusion of the C-terminus of ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(amino acids 133357"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "we cut out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0000925:Cut [Injury or Poisoning]
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]
   861   C1883724:CUT [Phenomenon or Process]

Phrase: "the fragment of MJD1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "from pAS2-1-MJD-20Q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1521048:20q [Nucleotide Sequence]

Phrase: "with EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "SalI"

Phrase: "and"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "this fragment into pBluescript II SK(+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.201: From this construct we cut out the fragment encoding amino acids 133249 of ataxin-3 with SmaI and BglII and subcloned it into the SmaI and BamHI sites of vector pAS2-1 to create pAS2-1-MJD(399747). 

Phrase: "From this construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "we cut out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0000925:Cut [Injury or Poisoning]
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]
   861   C1883724:CUT [Phenomenon or Process]

Phrase: "the fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 133249 of ataxin-3"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1538301:ATAXIN 3 [Gene or Genome]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "with SmaI"

Phrase: "and"

Phrase: "BglII"

Phrase: "and"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "it into the SmaI"

Phrase: "and"

Phrase: "BamHI sites of vector pAS2-1 to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pAS2-1-MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(399747"

Phrase: ")."
Processing 00000000.tx.202: We also cut out the C-terminus of MJD1 encoding amino acids 133357 from this construct and subcloned it into vector pAS2-1 to create pAS2-1-MJD(3991071). 

Phrase: "We also cut out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000925:Cut [Injury or Poisoning]
   827   C0439787:Out [Spatial Concept]
   827   C0849355:Out [Qualitative Concept]
   827   C1883724:CUT [Phenomenon or Process]

Phrase: "the C-terminus of MJD1"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 133357 from this construct"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C2827421:Construct [Classification]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "subcloned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1883178:Subclone [Cell]

Phrase: "it into vector pAS2-1 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pAS2-1-MJD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(3991071"

Phrase: ")."
Processing 00000000.tx.203: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.204: Primers for amplification (see Materials and Methods)  The following vectors, described elsewhere (32,33), were from Clontech: pVA3-1, which encodes a fusion of murine p53 protein (amino acids 72390) with the GAL4-BD, and pTD1-1, which encodes SV40 large T antigen (amino acids 87708) fused with the GAL4-AD, served as positive controls; 

Phrase: "Primers for amplification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "The following vectors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(32,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "were from Clontech"

Phrase: ":"

Phrase: "pVA3-1,"

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a fusion of murine p53 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(amino acids 72390"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "with the GAL4-BD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "pTD1-1,"

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "SV40 large T antigen"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0023043:Large T-Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C2243368:SV40 T-antigen [Molecular Function]
   861   C0003343:T-Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0549177:Large [Quantitative Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(amino acids 87708"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "fused with the GAL4-AD,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0699952:Fused [Functional Concept]
   753   C1416832:GAL4 [Gene or Genome]
   753   C1879547:Activation [Activity]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
   719 E C1414861:FUSE [Gene or Genome]
   719 E C1708111:Fuse [Manufactured Object]

Phrase: "served as positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   799   C1883676:Positive Control [Conceptual Entity]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.205: pLAM5'-1, which encodes a fusion protein of human lamin C protein (amino acids 66230) with the GAL4-BD, was the negative control. 

Phrase: "pLAM5'-1,"

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a fusion protein of human lamin C protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   789   C1271487:Protein C human [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   767   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1168438:Protein C [Laboratory Procedure]
   767   C1418943:PROTEIN C [Gene or Genome]
   767   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(amino acids 66230"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "with the GAL4-BD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "the negative control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.206: pET-21a(+)-MJD-CAG20, pET-21a(+)-MJD-CAG68 and pET-21a(+)-MJD-CAG80 were generated by subcloning full-length MJD1 from plasmids pAS2-1-MJD-CAG20, pAS2-1-MJD-CAG68 and pAS2-1-MJD-CAG80, respectively, via the NdeI and SalI sites, into pET-21a(+) (Novagen, Madison, WI). 

Phrase: "pET-21a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")-"

Phrase: "MJD-CAG20,"

Phrase: "pET-21a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")-"

Phrase: "MJD-CAG68"

Phrase: "and"

Phrase: "pET-21a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")-"

Phrase: "MJD-CAG80"

Phrase: "were"

Phrase: "generated by subcloning full-length MJD1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0443225:Full [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1538301:MJD1 [Gene or Genome]
   753   C1706316:LENGTH [Research Activity]
   753   C3146294:Generated [Activity]

Phrase: "from plasmids pAS2-1-MJD-CAG20,"

Phrase: "pAS2-1-MJD-CAG68"

Phrase: "and"

Phrase: "pAS2-1-MJD-CAG80,"

Phrase: "respectively,"

Phrase: "via the NdeI"

Phrase: "and"

Phrase: "SalI sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "into pET-21a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")"

Phrase: "(Novagen,"

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.207: pGEX-5x-1-HHR23A and pGEX-5x-1-HHR23B were obtained by subcloning full-length HHR23A or HHR23B from pACT2-HHR23A or pACT2-HHR23B into pGEX-5x-1 at the BamHI and XhoI sites. 

Phrase: "pGEX-5x-1-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "pGEX-5x-1-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1419237:HHR23B [Gene or Genome]
   812   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   812   C3541311:HHR23B [Gene or Genome]

Phrase: "were"

Phrase: "obtained by subcloning full-length HHR23A"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0443225:Full [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1419236:HHR23A [Gene or Genome]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   719 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "HHR23B from pACT2-HHR23A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1419237:HHR23B [Gene or Genome]
   770   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   770   C3541311:HHR23B [Gene or Genome]

Phrase: "or"

Phrase: "pACT2-HHR23B into pGEX-5x-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1419237:HHR23B [Gene or Genome]
   753   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   753   C3541311:HHR23B [Gene or Genome]

Phrase: "at the BamHI"

Phrase: "and"

Phrase: "XhoI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.208: Deletion mutants of the HHR23A and HHR23B genes were created by PCR using pACT2-HHR23A and pACT2-HHR23B as the templates. 

Phrase: "Deletion mutants of the HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "HHR23B genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "created by PCR"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1707531:Created By [Qualitative Concept]
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pACT2-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "pACT2-HHR23B as the templates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1419237:HHR23B [Gene or Genome]
   760   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   760   C3541311:HHR23B [Gene or Genome]
Processing 00000000.tx.209: Plasmid pGEX-HHR23A(1231) was created by subcloning the product from PCR with primers s1 and w50 into vector pGEX-5x-1 at the BamHI and XhoI sites; 

Phrase: "Plasmid pGEX-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419236:HHR23A [Gene or Genome]

Phrase: "(1231"

Phrase: ")"

Phrase: "was"

Phrase: "created by subcloning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the product from PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "with primers s1"

Phrase: "and"

Phrase: "w50 into vector pGEX-5x-1"

Phrase: "at the BamHI"

Phrase: "and"

Phrase: "XhoI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.210: pGEX-HHR23A(182) was created using primers s1 and w13; 

Phrase: "pGEX-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "(182"

Phrase: ")"

Phrase: "was"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers s1"

Phrase: "and"

Phrase: "w13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0148669:W13 [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.211: pGEX-HHR23A(232363) using primers w59 and w4; 

Phrase: "pGEX-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "(232363"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w59"

Phrase: "and"

Phrase: "w4"

Phrase: ";"
Processing 00000000.tx.212: pGEX-HHR23A(83363) using primers w14 and w4; 

Phrase: "pGEX-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "(83363"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w14"

Phrase: "and"

Phrase: "w4"

Phrase: ";"
Processing 00000000.tx.213: pGEX-HHR23B(1275) using primers w16 and w52; 

Phrase: "pGEX-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "(1275"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w16"

Phrase: "and"

Phrase: "w52"

Phrase: ";"
Processing 00000000.tx.214: pGEX-HHR23B(180) using primers w16 and w51; 

Phrase: "pGEX-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "(180"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w16"

Phrase: "and"

Phrase: "w51"

Phrase: ";"
Processing 00000000.tx.215: pGEX-HHR23B(276409) using primers w60 and w17; 

Phrase: "pGEX-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1419237:HHR23B [Gene or Genome]
   861   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   861   C3541311:HHR23B [Gene or Genome]

Phrase: "(276409"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w60"

Phrase: "and"

Phrase: "w17"

Phrase: ";"
Processing 00000000.tx.216: pGEX-HHR23A(81409) using primers w61 and w17. 

Phrase: "pGEX-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419236:HHR23A [Gene or Genome]

Phrase: "(81409"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers w61"

Phrase: "and"

Phrase: "w17."
Processing 00000000.tx.217: The ubiquitin gene was obtained by PCR using primers ubiquitin-F and ubiquitin-R from a human fetal spleen cDNA library (Clontech) and pGEX-ubiquitin was created by subcloning the PCR product into pGEX-5x-1 at the BamHI and SalI sites. 

Phrase: "The ubiquitin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers ubiquitin-F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "ubiquitin-R from a human fetal spleen cDNA library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205090:R- [Spatial Concept]
   742   C0684010:R. [Professional or Occupational Group]
   742   C2603358:R' [Clinical Attribute]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "and"

Phrase: "pGEX-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "created by subcloning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the PCR product into pGEX-5x-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "at the BamHI"

Phrase: "and"

Phrase: "SalI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.218: pcDNA3.1/v5-His-HHR23A and pEGFP-N1-HHR23A expression vectors were created by subcloning the PCR product from pACT2-HHR23A using pACT2-primer 2 and primer w69. 

Phrase: "pcDNA3.1/v5-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "His-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "pEGFP-N1-HHR23A expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vectors [Spatial Concept]
   771 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "created by subcloning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the PCR product from pACT2-HHR23A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pACT2-primer 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "primer w69."
Processing 00000000.tx.219: pEGFP-N1-MJD-CAG20 and pEGFP-N1-MJD-CAG80 were created by excising the MJD1 gene at the BamHI and StuI sites of pAS2-1-MJD-CAG20 and pAS2-1-MJD-CAG80 and subcloning the resultant fragments into vector pEGFP-N1 (Clontech) at the BglII and SmaI sites. 

Phrase: "pEGFP-N1-MJD-CAG20"

Phrase: "and"

Phrase: "pEGFP-N1-MJD-CAG80"

Phrase: "were"

Phrase: "created by excising"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the MJD1 gene at the BamHI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "StuI sites of pAS2-1-MJD-CAG20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   754   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "pAS2-1-MJD-CAG80"

Phrase: "and"

Phrase: "subcloning"

Phrase: "the resultant fragments into vector pEGFP-N1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "at the BglII"

Phrase: "and"

Phrase: "SmaI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.220: Using the instability of CAG in this construct, we obtained a further expanded construct containing 130 CAG repeats in vector pEGFP-N1. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the instability of CAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444783:Instability [Finding]

Phrase: "in this construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "a further expanded construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "130 CAG"

Phrase: "repeats in vector pEGFP-N1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205341:Repeat [Functional Concept]
   760   C0441962:N1 [Finding]
   760   C0442335:Vector [Spatial Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.221: pEGFP-N1-130Q, which expresses a mutant C-terminal fragment of ataxin-3, was created by excising a fragment from the MJD1 gene with BglII and StuI and subcloning it into vector pEGFP-N1 at the BglII and SmaI sites. 

Phrase: "pEGFP-N1-130Q,"

Phrase: "which"

Phrase: "expresses"

Phrase: "a mutant C-terminal fragment of ataxin-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C0332255:fragment [Functional Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "created by excising"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "a fragment from the MJD1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "with BglII"

Phrase: "and"

Phrase: "StuI"

Phrase: "and"

Phrase: "subcloning"

Phrase: "it into vector pEGFP-N1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441962:N1 [Finding]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "at the BglII"

Phrase: "and"

Phrase: "SmaI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.222: pREP10-MJD-CAG20 and pREP10-MJD-CAG80 were created by excising the MJD1 gene from pAS2-1-MJD-CAG20 and pAS2-1-MJD-CAG80 at the BamHI and SalI sites and subcloning the resultant fragments into vector pREP10 (Invitrogen, Carlsbad, CA) at the BamHI and XhoI sites. 

Phrase: "pREP10-MJD-CAG20"

Phrase: "and"

Phrase: "pREP10-MJD-CAG80"

Phrase: "were"

Phrase: "created by excising"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the MJD1 gene from pAS2-1-MJD-CAG20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017337:Gene [Gene or Genome]
   734   C1416989:MAL gene [Gene or Genome]

Phrase: "and"

Phrase: "pAS2-1-MJD-CAG80 at the BamHI"

Phrase: "and"

Phrase: "SalI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "subcloning"

Phrase: "the resultant fragments into vector pREP10"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA) at the BamHI"

Phrase: "and"

Phrase: "XhoI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.223: The fidelity of all constructs was confirmed by sequencing. 

Phrase: "The fidelity of all constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680011:fidelity [Social Behavior]

Phrase: "was"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.224: Two-hybrid screen The MATCHMARKER Two-Hybrid System 2 (Clontech) was used in this experiment. 

Phrase: "Two-hybrid screen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0599647:Two Hybrid [Molecular Biology Research Technique]
   827   C0020205:Hybrid [Organism]
   827   C0205448:Two [Quantitative Concept]
   827   C0220908:screen [Health Care Activity]
   827   C1305399:screen [Functional Concept]
   827   C1705053:Screen [Medical Device]

Phrase: "The MATCHMARKER Two-Hybrid System 2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0599647:Two Hybrid [Molecular Biology Research Technique]
   804   C0020205:Hybrid [Organism]
   804   C0205448:Two [Quantitative Concept]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "was"

Phrase: "used in this experiment."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1273517:used [Finding]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.225: All experiments were performed in yeast strain CG-1945. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in yeast strain CG-1945."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0080194:Strain [Injury or Poisoning]
   753   C0456178:strain [Intellectual Product]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C0884358:Performed [Functional Concept]
   753   C1518614:Strain [Organism]
   753   C2987481:Strain [Mental Process]
   753   C3540479:CG [Gene or Genome]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.226: Plasmids pAS2-1-MJD-CAG20, pAS2-1-MJD-CAG68 and pAS2-1-MJD-CAG80 were transformed into CG-1945 cells using the lithium acetate method according to the manual and the transformants then tested for the absence of autoactivation of the lacZ and HIS3 reporter genes and the absence of yeast cell toxicity. 

Phrase: "Plasmids pAS2-1-MJD-CAG20,"

Phrase: "pAS2-1-MJD-CAG68"

Phrase: "and"

Phrase: "pAS2-1-MJD-CAG80"

Phrase: "were"

Phrase: "transformed into CG-1945 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1510411:Transformed [Pathologic Function]
   760   C3282337:Cells [Cell]
   760   C3540479:CG [Gene or Genome]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the lithium acetate method according to the manual"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1285148:Manual method [Functional Concept]
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "the transformants then"

Phrase: "tested for the absence of autoactivation of the lacZ"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   742   C0022959:LacZ [Gene or Genome]
   742   C0332197:absence [Quantitative Concept]
   742   C0392366:tested [Intellectual Product]
   742   C1689985:Absence [Anatomical Abnormality]
   708 E C0022885:Test [Laboratory Procedure]
   708 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "HIS3 reporter genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206414:Genes, Reporter [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "the absence of yeast cell toxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.227: For the library screen, a single colony of CG-1945 cells transformed with pAS2-1-MJD-CAG20, pAS2-1-MJD-CAG68 or pAS2-1-MJD-CAG80 was grown overnight in SD-Trp medium and then transformed with a human fetal brain cDNA library constructed in vector pACT2 (Clontech). 

Phrase: "For the library screen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220908:screen [Health Care Activity]
   861   C1305399:screen [Functional Concept]
   861   C1705053:Screen [Medical Device]

Phrase: "a single colony of CG-1945 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439158:colony [Quantitative Concept]
   748   C1947989:Colony [Cell]

Phrase: "transformed with pAS2-1-MJD-CAG20,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0012634:Disease [Disease or Syndrome]
   748   C1510411:Transformed [Pathologic Function]
   746   C1425075:MALS-1 [Gene or Genome]

Phrase: "pAS2-1-MJD-CAG68"

Phrase: "or"

Phrase: "pAS2-1-MJD-CAG80"

Phrase: "was"

Phrase: "grown"

Phrase: "overnight in SD-Trp medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transformed with a human fetal brain cDNA library"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0440731:Fetal brain [Embryonic Structure]
   770   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0015965:Fetal [Embryonic Structure]
   744   C0023621:Library [Manufactured Object,Organization]
   744   C0086418:Human [Human]
   744   C0521457:Fetal [Functional Concept]
   744   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1510411:Transformed [Pathologic Function]

Phrase: "constructed in vector pACT2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   737   C2827421:Construct [Classification]

Phrase: "(Clontech"

Phrase: ")."
Processing 00000000.tx.228: Approximately 2 x 106 transformants were plated on SD-Trp-Leu-His selective plates, with 5 mM 3-AT used to limit false positives caused by leakage of HIS3 protein expression. 

Phrase: "Approximately 2 x 106 transformants"

Phrase: "were"

Phrase: "plated on SD-Trp-Leu-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1699992:Trp-Leu [Amino Acid, Peptide, or Protein]
   760   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726   C0005971:Plate [Medical Device]
   726   C1139930:plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]

Phrase: "His selective plates,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1139930:plates [Medical Device]
   827 E C0005971:Plate [Medical Device]
   827 E C3537155:Plate [Manufactured Object]

Phrase: "with 5 mM 3-AT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1418486:MM-1 [Gene or Genome]
   804   C0439084:>5 [Quantitative Concept]
   804   C0728893:+5 [Quantitative Concept]

Phrase: "3-AT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-AT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040880:Triazole [Organic Chemical]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "false positives"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0205557:false positives [Laboratory or Test Result]
   861   C0205237:False [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "caused by leakage of HIS3 protein expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1171362:protein expression [Genetic Function]
   748   C0015376:Leakage [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.229: After incubation at 30C for 57 days, all clones were subjected to -gal filter assays and patched on SD-Trp-Leu-His selective plates with 5 mM 3-AT for further analysis. 

Phrase: "After incubation"

Phrase: "at 30C"

Phrase: "for 57 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "all clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to -gal filter assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "patched on SD-Trp-Leu-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1367881:Patched [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "His selective plates with 5 mM 3-AT"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C1139930:plates [Medical Device]
   708 E C0005971:Plate [Medical Device]
   708 E C3537155:Plate [Manufactured Object]

Phrase: "3-AT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-AT for further analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040880:Triazole [Organic Chemical]
Processing 00000000.tx.230: Plasmid DNAs were isolated from the -gal-positive clones by growth in SD-Leu medium followed by transformation into E.coli HB101. 

Phrase: "Plasmid DNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "isolated from the -gal-positive clones"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0009013:Clones [Cell]
   753   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205409:Isolated [Functional Concept]
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1548221:Isolated [Idea or Concept]
   753   C2825490:Positive [Qualitative Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1522642:Clone [Tissue]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "in SD-Leu medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "followed by transformation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0040682:Transformation [Cell Function]
   790   C1510411:Transformation [Pathologic Function]
   790   C1705163:Transformation [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "into E.coli HB101."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0014834:E coli [Bacterium]
Processing 00000000.tx.231: The plasmids extracted from HB101 cells were first subjected to restriction enzyme analysis and those with library inserts then retransformed into CG-1945 cells harboring pAS2-1-MJD-CAG20, pAS2-1-MJD-CAG68 or pAS2-1-MJD-CAG80. 

Phrase: "The plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from HB101 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   770   C3541890:EXTRACTED [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2828366:Extract [Substance]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "subjected to restriction enzyme analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0035269:Restriction Enzyme Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "those with library"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0023621:Library [Manufactured Object,Organization]
   790   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inserts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441587:Insert [Health Care Activity]
  1000   C0813036:Inserts [Medical Device]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "retransformed into CG-1945 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3282337:Cells [Cell]
   760   C3540479:CG [Gene or Genome]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "pAS2-1-MJD-CAG20,"

Phrase: "pAS2-1-MJD-CAG68"

Phrase: "or"

Phrase: "pAS2-1-MJD-CAG80."
Processing 00000000.tx.232: The cells were selected on SD-Trp-Leu-His plates with 5 mM 3-AT. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "selected on SD-Trp-Leu-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1699992:Trp-Leu [Amino Acid, Peptide, or Protein]
   760   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   726   C1707391:Select [Activity]

Phrase: "His plates with 5 mM 3-AT"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C1139930:plates [Medical Device]
   711 E C0005971:Plate [Medical Device]
   711 E C3537155:Plate [Manufactured Object]

Phrase: "3-AT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-AT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040880:Triazole [Organic Chemical]
Processing 00000000.tx.233: The resulting transformants that were positive in -gal filter assays were sequenced around the junction of the GAL4-AD and the inserted target protein using pACT2 primer 2 or reverse insert primer. 

Phrase: "The resulting transformants"

Phrase: "that"

Phrase: "were"

Phrase: "positive in -gal filter assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "sequenced around the junction of the GAL4-AD"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0205144:Junction [Spatial Concept]
   742   C1416832:GAL4 [Gene or Genome]
   742   C1706311:Junction [Medical Device]
   742   C1879547:Activation [Activity]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
   708   C0004793:Sequence [Nucleotide Sequence]
   708   C0162326:Sequence [Nucleotide Sequence]
   708   C0162327:Sequence [Nucleotide Sequence]
   708   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "the inserted target protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pACT2 primer 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "reverse insert primer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.234: In order to characterize binding between ataxin-3 and HHR23B, plasmids pACT2-HHR23B and pAS2-1-MJDs were co-transformed into yeast and the cells grown on selection plates. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "characterize"

Phrase: "binding between ataxin-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "HHR23B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "plasmids pACT2-HHR23B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1419237:HHR23B [Gene or Genome]
   827   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
   827   C3541311:HHR23B [Gene or Genome]

Phrase: "and"

Phrase: "pAS2-1-MJDs"

Phrase: "were"

Phrase: "co-transformed into yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1510411:Transformed [Pathologic Function]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "grown on selection plates."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0036576:selection [Genetic Function]
   770   C1139930:plates [Medical Device]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.235: The transformants were also examined by -gal filter assays. 

Phrase: "The transformants"

Phrase: "were"

Phrase: "also"

Phrase: "examined by -gal filter assays."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0180860:Filter [Manufactured Object]
   760   C0332128:Examined [Finding]
   760   C0581406:Filter [Medical Device]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.236: For liquid -gal assays the yeast cells were cultured overnight in SD-Trp-Leu selection medium until the cells were in mid log phase (OD600 of 1 ml = 0.50.8). 

Phrase: "For liquid -gal assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "the yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "overnight in SD-Trp-Leu selection medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1699992:Trp-Leu [Amino Acid, Peptide, or Protein]
   748   C0009458:Medium [Intellectual Product]
   748   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0036576:selection [Genetic Function]
   748   C0439536:Medium [Quantitative Concept]
   748   C0439583:Overnight [Temporal Concept]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "until the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were in mid log phase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205390:Phase [Temporal Concept]
   760   C1708728:Log [Intellectual Product]
   760   C2986775:log [Occupational Activity]

Phrase: "(OD600 of 1 ml = 0.50.8"

Phrase: ")."
Processing 00000000.tx.237: The cells were collected and assays were performed using o-nitrophenyl--D-galactopyranoside (ONPG) (Sigma, St Louis, MO) as substrate according to the protocol. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "o-nitrophenyl--D-galactopyranoside (ONPG)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]
   812   C0439114:O NOS [Intellectual Product]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "as"

Phrase: "substrate according to the protocol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.238: In vitro binding assay An aliquot containing 20 g of protein from the soluble fraction of E.coli cell lysates expressing GSTHHR23A, GSTHHR23B or GSTubiquitin was incubated with 20 l of glutathioneagarose beads (1:1 slurry) (Amersham Pharmacia Biotech) for 20 min at room temperature. 

Phrase: "In vitro binding assay"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C1515653:In Vitro Assay [Research Activity]
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "An aliquot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510844:Aliquot [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: "from the soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of E.coli cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "expressing"

Phrase: "GSTHHR23A,"

Phrase: "GSTHHR23B"

Phrase: "or"

Phrase: "GSTubiquitin"

Phrase: "was"

Phrase: "incubated with 20 l of glutathioneagarose beads"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0991566:Beads [Biomedical or Dental Material]
   748   C1439852:Incubated [Laboratory Procedure]
   714 E C2346972:Bead [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 slurry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883043:Slurry [Substance]

Phrase: ")"

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.239: After washing three times with phosphate-buffered saline (PBS), beads bound with GSTHHR23A or GSTHHR23B were incubated with 50 g of protein from the supernatants of E.coli crude extracts containing recombinant ataxin-3-Q20, ataxin-3-Q68 or ataxin-3-Q80 expressed from pET-21a(+)-MJD-CAG20, pET-21a(+)-MJD-CAG68 or pET-21a(+)-MJD-CAG80, respectively, or the supernatant from lymphoblastoid cell lines, 293 cells, control and MJD brains in 0.25 ml of HNTG buffer (20 mM HEPESKOH, pH 7.5, 100 mM NaCl, 0.1% Triton X-100 and 10% glycerol) (19) for 1 h at 4C. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "three times with phosphate-buffered saline (PBS),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "bound with GSTHHR23A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "or"

Phrase: "GSTHHR23B"

Phrase: "were"

Phrase: "incubated with 50 g of protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "from the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "of E.coli crude extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1258023:Crude Extracts [Chemical]
   779   C2828366:Extract [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "recombinant ataxin-3-Q20,"

Phrase: "ataxin-3-Q68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "or"

Phrase: "ataxin-3-Q80"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "expressed from pET-21a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031268:Pet [Animal]
   770   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")-"

Phrase: "MJD-CAG20,"

Phrase: "pET-21a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")-"

Phrase: "MJD-CAG68"

Phrase: "or"

Phrase: "pET-21a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553659:21a [Medical Device]

Phrase: "(+"

Phrase: ")-"

Phrase: "MJD-CAG80,"

Phrase: "respectively,"

Phrase: "or"

Phrase: "the supernatant from lymphoblastoid cell lines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1550101:Supernatant [Body Substance]

Phrase: "293 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MJD brains in 0.25 ml of HNTG buffer"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0006111:Disease of brain, NOS [Disease or Syndrome]
           Brain Disease
   739   C0006104:Brains [Body Part, Organ, or Organ Component]
   706 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(20 mM HEPESKOH,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "10% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "(19"

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.240: After incubation the beads were washed four times with 1 ml of HNTG buffer to remove unbound protein. 

Phrase: "After incubation"

Phrase: "the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times with 1 ml of HNTG buffer to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0040223:times [Temporal Concept]
   742   C1632851:Times [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "unbound protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.241: Bound proteins were eluted from the beads by boiling in SDS sample buffer and detected by immunoblot analysis using a monoclonal anti-ataxin-3 antibody, MJ2-5-3 (7). 

Phrase: "Bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted from the beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0991566:Beads [Biomedical or Dental Material]
   737 E C2346972:Bead [Spatial Concept]

Phrase: "by boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "in SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "detected by immunoblot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monoclonal anti-ataxin-3 antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "MJ2-5-3"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.242: Cell culture and transfection 293 cells cultured overnight in Dulbeccos modified Eagles medium (DMEM) (Gibco, Rockville, MD) medium containing 10% calf serum (CS) were washed with Opti-MEM and then transfected with expressing vectors using LipofectAMINE 2000 reagent (Gibco) in Opti-MEM medium without serum. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transfection 293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "overnight in Dulbeccos modified Eagles medium (DMEM)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagles [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C1551720:Eagle [Population Group]

Phrase: "(Gibco,"

Phrase: "Rockville,"

Phrase: "MD) medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% calf serum (CS)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "were"

Phrase: "washed with Opti-MEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transfected with expressing vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LipofectAMINE 2000 reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   734   C1312445:lipofectamine 2000 [Organic Chemical]

Phrase: "(Gibco"

Phrase: ")"

Phrase: "in Opti-MEM medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "without serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]
Processing 00000000.tx.243: The same volume of DMEM containing 10% CS was added to the culture medium 6 h after transfection. 

Phrase: "The same volume of DMEM"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0009458:Medium [Intellectual Product]
   744   C0325564:Eagles [Bird]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C1705217:Medium [Substance]
   744   C2700258:Volume [Laboratory Procedure]
   744   C3244283:medium [Intellectual Product]
   711 E C1551720:Eagle [Population Group]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% CS"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the culture medium 6 h"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   778   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   774   C0444953:H 6 [Intellectual Product]
   748   C0009458:Medium [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0220814:culture [Functional Concept]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439536:Medium [Quantitative Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1705217:Medium [Substance]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3244283:medium [Intellectual Product]
   714 E C1883712:Add [Functional Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.244: After 48 h the transfected cells were observed using an inverted system microscope (Olympus, Tokyo, Japan) or used for immunofluorescence staining, immunoblot analysis or immunoprecipitation. 

Phrase: "After 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an inverted system microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0181839:Microscope [Medical Device]
   827   C1706379:Microscope [Medical Device]

Phrase: "(Olympus,"

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "used for immunofluorescence staining,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1704680:Staining [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "or"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.245: Immunofluorescence Cells transfected with pcDNA3.1/v5-His-HHR23A or co-transfected with pEGFP-N1-MJDs and pcDNA3.1/v5-His-HHR23A were fixed in PBS with 4% paraformaldehyde for 5 min and then treated with 0.25% Triton X-100 for 5 min. 

Phrase: "Immunofluorescence Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pcDNA3.1/v5-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "His-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "or"

Phrase: "co-transfected with pEGFP-N1-MJDs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441962:N1 [Finding]

Phrase: "and"

Phrase: "pcDNA3.1/v5-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "His-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "were"

Phrase: "fixed in PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C2827483:Fixed [Body Substance]

Phrase: "with 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 0.25% Triton X-100"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0242759:Triton [Geographic Area]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.246: After blocking in 4% bovine serum albumin in PBS for 1 h, the cells were incubated with monoclonal anti-v5 antibody (1:2000; 

Phrase: "After"

Phrase: "blocking in 4% bovine serum albumin"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocking [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0028778:Block [Pathologic Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with monoclonal anti-v5 antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.247: Invitrogen) overnight at 4C. 

Phrase: "Invitrogen"

Phrase: ")"

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.248: After washing with PBS the cells were incubated with Cy3-labeled goat anti-mouse antibodies (1:800) (Santa Cruz Biotechnology, Santa Cruz, CA) at room temperature for 1 h. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with Cy3-labeled goat anti-mouse antibodies"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   767   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018019:goat [Mammal]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C1265549:goat [Mammal]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1510458:Goat [Mammal]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "800"

Phrase: ")"

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA) at room temperature"

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.249: Sections were then examined using a confocal microscope (Fluoview) (Olympus). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a confocal microscope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1626420:Confocal microscope [Medical Device]
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "(Fluoview"

Phrase: ")"

Phrase: "(Olympus"

Phrase: ")."
Processing 00000000.tx.250: Immunoprecipitation 293 cells co-transfected with pEGFP-N1 or pEGFP-N1-HHR23A and pREP10-MJD-CAG20 or pREP10-MJD-CAG80 were collected 48 h after transfection. 

Phrase: "Immunoprecipitation 293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected with pEGFP-N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441962:N1 [Finding]

Phrase: "or"

Phrase: "pEGFP-N1-HHR23A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419236:HHR23A [Gene or Genome]

Phrase: "and"

Phrase: "pREP10-MJD-CAG20"

Phrase: "or"

Phrase: "pREP10-MJD-CAG80"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "48 h after transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.251: The cells were sonicated in TSPI buffer (50 mM TrisHCl, pH 7.5, 150 mM sodium chloride, 1 mM EDTA, 1 g/ml aprotinin, 10 g/ml leupeptin, 0.5 M Pefabloc SC and 10 g/ml pepstain) containing 1% NP-40. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "sonicated in TSPI buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50 mM TrisHCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM sodium chloride,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0037494:Sodium Chloride [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0596019:Chloride [Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "0.5 M Pefabloc SC"

Phrase: "and"

Phrase: "10 g/ml pepstain"

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% NP-40."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0044508:1-NP [Hazardous or Poisonous Substance,Organic Chemical]
   901   C0068941:NP-40 [Organic Chemical,Pharmacologic Substance]
   827   C0439509:/40 [Temporal Concept]
   827   C1706141:NP [Gene or Genome]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
Processing 00000000.tx.252: Cellular debris was removed by centrifugation at 16 000 g for 15 min at 4C. 

Phrase: "Cellular debris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]

Phrase: "was"

Phrase: "removed by centrifugation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "at 16 000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.253: The supernatants were then preincubated with protein GSepharose (Amersham Pharmacia Biotech) for 2 h at 4C and then incubated with monoclonal anti-GFP antibody (Boehringer Mannheim, Mannheim, Germany) for 1 h at 4C. 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "preincubated with protein GSepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with monoclonal anti-GFP antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0746619:monoclonal [Finding]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Boehringer Mannheim,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.254: After incubation protein GSepharose was used for precipitation. 

Phrase: "After incubation protein GSepharose"

Phrase: "was"

Phrase: "used for precipitation."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1273517:used [Finding]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C2584299:Precipitation [Natural Phenomenon or Process]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.255: The beads were washed with TSPI buffer four times and then eluted with SDS sample buffer for immunoblot analysis. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed with TSPI buffer four times"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0040223:times [Temporal Concept]
   753   C0205450:Four [Quantitative Concept]
   753   C1548982:Washed [Idea or Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C0441648:Wash [Activity]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "eluted with SDS sample buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "for immunoblot analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.256: Immunoblot analysis Proteins were separated by 10% SDSPAGE or 520% gradient SDSPAGE and then transferred to polyvinylidene difluoride membrane (Millipore, Bedford, MA). 

Phrase: "Immunoblot analysis Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0020985:Immunoblot Analysis [Laboratory Procedure]

Phrase: "were"

Phrase: "separated by 10% SDSPAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]

Phrase: "or"

Phrase: "520% gradient SDSPAGE"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to polyvinylidene difluoride membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.257: The primary antibodies used were MJ2-5-3 antibody (7) and monoclonal anti-GFP antibody. 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "MJ2-5-3 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "monoclonal anti-GFP antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.258: Sheep anti-mouse IgG-HRP antibody (Amersham Pharmacia Biotech) was used as the secondary antibody. 

Phrase: "Sheep anti-mouse IgG-HRP antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   839   C2754943:IgG antibody [Cell Component]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "was"

Phrase: "used as the secondary antibody."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.259: The proteins were visualized using an ECL detection kit (Amersham Pharmacia Biotech).  

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ECL detection kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.260: ACKNOWLEDGEMENT  This work was partly supported by a grant from the Ministry of Health and Welfare.  

Phrase: "ACKNOWLEDGEMENT"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "partly"

Phrase: "supported by a grant"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   770   C1548284:Grant [Idea or Concept]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Ministry of Health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018684:Health [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "Welfare."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037440:welfare [Self-help or Relief Organization]
Processing 00000000.tx.261: FOOTNOTES  + To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.262: Tel: +81 48 467 9702; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+81 48 467 9702"

Phrase: ";"
Processing 00000000.tx.263: Fax: +81 48 462 4796; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+81 48 462 4796"

Phrase: ";"
Processing 00000000.tx.264: Email: nukina@brain.riken.go.jp  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Rosenberg, R.N. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "nukina@brain.riken."

Phrase: "go.jp"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979969:Rosenberg [Spatial Concept]

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.265: (1992) MachadoJoseph disease: an autosomal dominant motor system degeneration. 

Phrase: "(1992"

Phrase: ")"

Phrase: "MachadoJoseph disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an autosomal dominant motor system degeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011164:Degeneration [Pathologic Function]
   804   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.266: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.267: Disord., 7, 193203.[ISI][Medline] 2 Takiyama, Y., Nishizawa, M., Tanaka, H., Kawashima, S., Sakamoto, H., Karube, Y., Shimazaki, H., Soutome, M., Endo, K., Ohta, S. et al. 

Phrase: "Disord.,"

Phrase: "7,"

Phrase: "193203."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 2 Takiyama,"

Phrase: "Y.,"

Phrase: "Nishizawa,"

Phrase: "M."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kawashima,"

Phrase: "S."

Phrase: ","

Phrase: "Sakamoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Karube,"

Phrase: "Y.,"

Phrase: "Shimazaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Soutome,"

Phrase: "M."

Phrase: ","

Phrase: "Endo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014175:Endo [Disease or Syndrome]
  1000   C1427293:ENDO [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ohta,"

Phrase: "S. et al."
Processing 00000000.tx.268: (1993) The gene for MachadoJoseph disease maps to human chromosome 14q. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The gene for MachadoJoseph disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1416989:MAL gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "maps to human chromosome 14q."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0008643:Human Chromosome [Cell Component]
   806   C1327813:chromosome 14q [Nucleotide Sequence]
           14q
   797   C0814036:chromosome map [Intellectual Product]
   760   C0008633:Chromosome [Cell Component]
   760   C0024779:Map [Manufactured Object]
   760   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086418:Human [Human]
   760   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.269: Nature Genet., 4, 300304.[ISI][Medline] 3 Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Makamura, S., Nishimura, M., Akiguchi, I. et al. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "300304."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Kawaguchi,"

Phrase: "Y.,"

Phrase: "Okamoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Taniwaki,"

Phrase: "M."

Phrase: ","

Phrase: "Aizawa,"

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "M."

Phrase: ","

Phrase: "Katayama,"

Phrase: "S."

Phrase: ","

Phrase: "Kawakami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Makamura,"

Phrase: "S."

Phrase: ","

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Akiguchi,"

Phrase: "I. et al."
Processing 00000000.tx.270: (1994) CAG expansions in a novel gene for MachadoJoseph disease at chromosome 14q32.1. 

Phrase: "(1994"

Phrase: ")"

Phrase: "CAG expansions in a novel gene"

Phrase: "for MachadoJoseph disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "at chromosome 14q32.1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0008651:Chromosome 1 [Cell Component]
   901   C1520600:14q32.1 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C1520599:14q32 [Cell Component]
Processing 00000000.tx.271: Nature Genet., 8, 221228.[ISI][Medline] 4 Ross, C.A. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "221228."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 4 Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331968:Ross [Health Care Related Organization]
   861   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.272: (1995) When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. 

Phrase: "(1995"

Phrase: ")"

Phrase: "When"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: ":"

Phrase: "pathogenesis of glutamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0543483:pathogenesis [Functional Concept]
   790   C0699748:Pathogenesis [Pathologic Function]

Phrase: "repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205341:Repeat [Functional Concept]
  1000   C1547730:Repeat [Temporal Concept]
  1000   C1705914:Repeat [Conceptual Entity]

Phrase: "neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.273: Neuron, 15, 493496.[ISI][Medline] 5 Nishiyama, K., Murayama, S., Goto, J., Watanabe, M., Hashida, H., Katayama, S., Nomura, Y., Nakamura, S. and Kanazawa, I. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "15,"

Phrase: "493496."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Nishiyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "S."

Phrase: ","

Phrase: "Goto,"

Phrase: "J.,"

Phrase: "Watanabe,"

Phrase: "M."

Phrase: ","

Phrase: "Hashida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Katayama,"

Phrase: "S."

Phrase: ","

Phrase: "Nomura,"

Phrase: "Y.,"

Phrase: "Nakamura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.274: (1996) Regional and cellular expression of the MachadoJoseph disease gene in brain of normal and affected individuals. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Regional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205147:regional [Spatial Concept]
  1000   C0205276:Regional [Spatial Concept]
  1000   C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "cellular expression of the MachadoJoseph disease gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "affected individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.275: Ann. 

Phrase: "Ann."
Processing 00000000.tx.276: Neurol., 40, 776781.[ISI][Medline] 6 Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D., Fischbeck, K.H. and Pittman, R.N. 

Phrase: "Neurol.,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "776781."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6 Paulson,"

Phrase: "H.L., Das,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   827   C0057671:DAS [Organic Chemical,Pharmacologic Substance]
   734   C2346686:h l [Quantitative Concept]

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Crino,"

Phrase: "P.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1539794:P-B [Gene or Genome]

Phrase: "Perez,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Patel,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Gotsdiner,"

Phrase: "D."

Phrase: ","

Phrase: "Fischbeck,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pittman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.277: (1997) MachadoJoseph disease gene product is a cytoplasmic protein widely expressed in brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "MachadoJoseph disease gene product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "a cytoplasmic protein widely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.278: Ann. 

Phrase: "Ann."
Processing 00000000.tx.279: Neurol., 41, 453462.[ISI][Medline] 7 Wang, G., Ide, K., Nukina, N., Goto, J., Ichikawa, Y., Uchida, K., Sakamoto, T. and Kanazawa, I. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "453462."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 7 Wang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Goto,"

Phrase: "J.,"

Phrase: "Ichikawa,"

Phrase: "Y.,"

Phrase: "Uchida,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakamoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.280: (1997) MachadoJoseph disease gene product identified in lymphocytes and brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "MachadoJoseph disease gene product"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   833   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "identified in lymphocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0024264:Lymphocytes [Cell]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.281: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.282: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.283: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.284: Commun., 233, 476479.[ISI][Medline] 8 Tait, D., Riccio, M., Sittler, A., Scherzinger, E., Santi, S., Ognibene, A., Maraldi, N.M., Lehrach, H. and Wanker, E.E. 

Phrase: "Commun.,"

Phrase: "233,"

Phrase: "476479."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Tait,"

Phrase: "D."

Phrase: ","

Phrase: "Riccio,"

Phrase: "M."

Phrase: ","

Phrase: "Sittler,"

Phrase: "A.,"

Phrase: "Scherzinger,"

Phrase: "E.,"

Phrase: "Santi,"

Phrase: "S."

Phrase: ","

Phrase: "Ognibene,"

Phrase: "A.,"

Phrase: "Maraldi,"

Phrase: "N.M.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Lehrach,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wanker,"

Phrase: "E.E."
Processing 00000000.tx.285: (1998) Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ataxin-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "is"

Phrase: "transported into the nucleus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1526989:nucleus transport [Cell Function]
   770   C0007610:Nucleus [Cell Component]
   737   C0005528:Transport, NOS [Cell Function]
   737   C1317949:Transport [Manufactured Object]
   737   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "associates with the nuclear matrix."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0028581:Nuclear Matrix [Cell Component]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0750490:Associate [Idea or Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C1706515:Matrix [Body Substance]
Processing 00000000.tx.286: Hum. 

Phrase: "Hum."
Processing 00000000.tx.287: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.288: Genet., 7, 991997.[Abstract/Free FullText] 9 Evert, B.O., Wullner, U., Schulz, J.B., Weller, M., Groscurth, P., Trottier, Y., Brice, A. and Klockgether, T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "991997."

Phrase: "[Abstract/Free FullText"

Phrase: "] 9"

Phrase: "Evert"

Phrase: ","

Phrase: "B.O.,"

Phrase: "Wullner,"

Phrase: "U.,"

Phrase: "Schulz,"

Phrase: "J.B.,"

Phrase: "Weller,"

Phrase: "M."

Phrase: ","

Phrase: "Groscurth,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trottier,"

Phrase: "Y.,"

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Klockgether,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.289: (1999) High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. 

Phrase: "(1999"

Phrase: ")"

Phrase: "High level expression of expanded full-length ataxin-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C3244092:expression level [Idea or Concept]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "formation of intranuclear inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "in neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.290: Hum. 

Phrase: "Hum."
Processing 00000000.tx.291: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.292: Genet., 8, 11691176.[Abstract/Free FullText] 10 Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S. and Kakizuka, A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "11691176."

Phrase: "[Abstract/Free FullText"

Phrase: "] 10 Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamaguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Sugai,"

Phrase: "S."

Phrase: ","

Phrase: "Aze,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004486:AZE [Geographic Area]

Phrase: "Y.,"

Phrase: "Narumiya,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kakizuka,"

Phrase: "A."
Processing 00000000.tx.293: (1996) Expanded polyglutamine in the MachadoJoseph disease protein induces cell death in vitro and in vivo. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Expanded polyglutamine in the MachadoJoseph disease protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.294: Nature Genet., 13, 196202.[ISI][Medline] 11 Paulson, H.L., Perez, M.K., Trottier, Y., Trojanowski, J.Q., Subramony, S.H., Das, S.S., Vig, P., Mandel, J.L., Fischbeck, K.H. and Pittman, R.N. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "13,"

Phrase: "196202."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 Paulson,"

Phrase: "H.L., Perez,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Trottier,"

Phrase: "Y.,"

Phrase: "Trojanowski,"

Phrase: "J.Q., Subramony,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Vig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0281471:VIG [Therapeutic or Preventive Procedure]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mandel,"

Phrase: "J.L., Fischbeck,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pittman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.295: (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Intranuclear inclusions of expanded polyglutamine protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1366904:Intranuclear Inclusions [Cell Component]
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "in spinocerebellar ataxia type 3."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441731:Type 3 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]
Processing 00000000.tx.296: Neuron, 19, 333344.[ISI][Medline] 12 Perez, M.K., Paulson, H.L., Pendse, S.J., Saionz, S.J., Bonini, N.M. and Pittman, R.N. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "19,"

Phrase: "333344."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Perez,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Paulson,"

Phrase: "H.L., Pendse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "S."

Phrase: "J.,"

Phrase: "Saionz,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Bonini,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Pittman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.297: (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "and"

Phrase: "the role of nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in polyglutamine-mediated aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.298: J. 

Phrase: "J."
Processing 00000000.tx.299: Cell Biol., 143, 14571470.[Abstract/Free FullText] 13 Cooper, A.J.L., Sheu, K.-F.R., Burke, J.R., Strittmatter, W.J., Gentile, V., Peluso, G. and Blass, J.P. 

Phrase: "Cell Biol.,"

Phrase: "143,"

Phrase: "14571470."

Phrase: "[Abstract/Free FullText"

Phrase: "] 13 Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0335912:Cooper [Professional or Occupational Group]

Phrase: "A.J.L., Sheu,"

Phrase: "K.-F.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Burke"

Phrase: ","

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Gentile,"

Phrase: "V.,"

Phrase: "Peluso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Blass,"

Phrase: "J.P."
Processing 00000000.tx.300: (1999) Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the row of tissue transglutaminase and to selective vulnerability. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0543483:pathogenesis [Functional Concept]
   739   C0699748:Pathogenesis [Pathologic Function]

Phrase: "with special reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: "to the row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552846:Row [Idea or Concept]

Phrase: "of tissue transglutaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "and to selective vulnerability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.301: J. 

Phrase: "J."
Processing 00000000.tx.302: Neurochem., 72, 889899.[ISI][Medline] 14 Masutani, C., Sugasawa, K., Yanagisawa, J., Sonoyama, T., Ui, M., Enomoto, T., Takio, K., Tanaka, K., van der Spek, P.J., Bootsma, D. et al. 

Phrase: "Neurochem.,"

Phrase: "72,"

Phrase: "889899."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 14 Masutani,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sugasawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yanagisawa,"

Phrase: "J.,"

Phrase: "Sonoyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ui,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421312:UI [Gene or Genome]
  1000   C2349022:UI [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Enomoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.J.,"

Phrase: "Bootsma,"

Phrase: "D. et al."
Processing 00000000.tx.303: (1994) Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "cloning of a nucleotide excision repair complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0009015:Cloning [Research Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the xeroderma pigmentosum group C protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1421540:xeroderma pigmentosum group C protein [Gene or Genome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C2752147:Xeroderma pigmentosum group C [Congenital Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "a human homologue of yeast RAD23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.304: EMBO J., 13, 18311843.[Abstract] 15 Masutani, C., Araki, M., Sugasawa, K., van der Spek, P.J., Yamada, A., Uchida, A., Maekawa, T., Bootsma, D., Hoeijmakers, J.H.J. and Hanaoka, F. 

Phrase: "EMBO J.,"

Phrase: "13,"

Phrase: "18311843."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 15 Masutani,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Araki,"

Phrase: "M."

Phrase: ","

Phrase: "Sugasawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.J.,"

Phrase: "Yamada,"

Phrase: "A.,"

Phrase: "Uchida,"

Phrase: "A.,"

Phrase: "Maekawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bootsma,"

Phrase: "D."

Phrase: ","

Phrase: "Hoeijmakers,"

Phrase: "J.H.J."

Phrase: "and"

Phrase: "Hanaoka,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.305: (1997) Identification and characterization of XPC-binding domain of hHR23B. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of XPC-binding domain of hHR23B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]
Processing 00000000.tx.306: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.307: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.308: Biol., 17, 69156923.[Abstract] 16 van der Spek, P.J., Eker, A., Rademakers, S., Visser, C., Sugasawa, K., Masutani, C., Hanaoka, F., Bootsma, D. and Hoeijmamers, J.H.J. 

Phrase: "Biol.,"

Phrase: "17,"

Phrase: "69156923."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 16 van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557775:Van [Manufactured Object]
   812   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.J.,"

Phrase: "Eker,"

Phrase: "A.,"

Phrase: "Rademakers,"

Phrase: "S."

Phrase: ","

Phrase: "Visser,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sugasawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masutani,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hanaoka,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bootsma,"

Phrase: "D."

Phrase: "and"

Phrase: "Hoeijmamers,"

Phrase: "J.H.J."
Processing 00000000.tx.309: (1996) XPC and human homologs of RAD23: intracellular localization and relationship to other nucleotide excision repair complexes. 

Phrase: "(1996"

Phrase: ")"

Phrase: "XPC"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C2752147:Xeroderma pigmentosum group C [Congenital Abnormality,Disease or Syndrome]
   861   C0043346:Xeroderma Pigmentosum [Congenital Abnormality]
   861   C0441837:Group C [Classification]
   812   C0043345:Xeroderma [Disease or Syndrome]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "human homologs of RAD23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1334043:Homolog [Gene or Genome]

Phrase: ":"

Phrase: "intracellular localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1660749:intracellular localization [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "relationship to other nucleotide excision repair complexes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.310: Nucleic Acids Res., 24, 25512559.[Abstract/Free FullText] 17 Li, X.J., Li, S.H., Sharp, A.H., Nucifora Jr, F.C., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. 

Phrase: "Nucleic Acids Res.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "24,"

Phrase: "25512559."

Phrase: "[Abstract/Free FullText"

Phrase: "] 17 Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nucifora Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "F.C., Schilling,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lanahan,"

Phrase: "A.,"

Phrase: "Worley,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Snyder,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.311: (1995) A huntingtin-associated protein enriched in brain with implications for pathology. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A huntingtin-associated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enriched in brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C0359583:enriched [Food]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with implications"

Phrase: "for pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.312: Nature, 378, 398402.[ISI][Medline] 18 Kalchman, M.A., Koide, H.B., McCutcheon, K., Graham, R.K., Nichol, K., Nishiyama, K., Kazemi-Esfariani, P., Lynn, F.C., Wellington, C., Metzler, M. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "378,"

Phrase: "398402."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 18 Kalchman,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Koide,"

Phrase: "H.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]

Phrase: "McCutcheon,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Graham,"

Phrase: "R.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nichol,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nishiyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kazemi-Esfariani,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lynn,"

Phrase: "F.C., Wellington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0453965:wellington [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Metzler,"

Phrase: "M. et al."
Processing 00000000.tx.313: (1997) HIP1, a human homologue of S.cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. 

Phrase: "(1997"

Phrase: ")"

Phrase: "HIP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a human homologue of S.cerevisiae Sla2p,"

Phrase: "interacts with membrane-associated huntingtin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   797   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0025255:Membrane [Tissue]
   760   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1415504:HUNTINGTIN [Gene or Genome]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.314: Nature Genet., 16, 4453.[ISI][Medline] 19 Sittler, A., Walter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., Bates, G.P., Lehrach, H. and Wanker, E.E. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "16,"

Phrase: "4453."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 19 Sittler,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "S."

Phrase: ","

Phrase: "Wedemeyer,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hasenbank,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Scherzinger,"

Phrase: "E.,"

Phrase: "Eickhoff,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bates"

Phrase: ","

Phrase: "G.P.,"

Phrase: "Lehrach,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wanker,"

Phrase: "E.E."
Processing 00000000.tx.315: (1998) SH3GL3 associates with the huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. 

Phrase: "(1998"

Phrase: ")"

Phrase: "SH3GL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420027:SH3GL3 [Gene or Genome]

Phrase: "associates with the huntingtin exon 1 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0252274:Huntingtin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0750490:Associate [Idea or Concept]
   748   C1415504:HUNTINGTIN [Gene or Genome]
   748   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of polygln-containing protein aggregates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597295:protein formation [Molecular Function]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.316: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.317: Cell, 2, 427436.[ISI][Medline] 20 Okamura-Oho, Y., Miyashita, T., Ohmi, K. and Yamada, M. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "427436."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 20 Okamura-Oho,"

Phrase: "Y.,"

Phrase: "Miyashita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ohmi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yamada,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.318: (1999) Dentatorubral-pallidoluysian atrophy protein interacts through a proline-rich region near polyglutamine with the SH3 domain of an insulin receptor tyrosine kinase substrate. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Dentatorubral-pallidoluysian atrophy protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0380757:dentatorubral-pallidoluysian atrophy protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]

Phrase: "interacts through a proline-rich region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1514490:Proline-Rich Region [Amino Acid Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0033382:Proline [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205147:Region [Spatial Concept]
   753   C0699759:Rich [Qualitative Concept]

Phrase: "near polyglutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]

Phrase: "with the SH3 domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0282535:SH3 Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of an insulin receptor tyrosine kinase substrate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1538314:INSULIN RECEPTOR TYROSINE KINASE SUBSTRATE [Gene or Genome]
   804   C1710236:Substrate [Manufactured Object]
   771   C0915518:insulin receptor tyrosine kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.319: Hum. 

Phrase: "Hum."
Processing 00000000.tx.320: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.321: Genet., 8, 947957.[Abstract/Free FullText] 21 Wood, J.D., Yuan, J., Margolis, R.L., Colomer, V., Duan, K., Kushi, J., Kaminsky, Z., Kieiderlein, J.J., Sharp, A.H. and Ross, C.A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "947957."

Phrase: "[Abstract/Free FullText"

Phrase: "] 21 Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Yuan,"

Phrase: "J.,"

Phrase: "Margolis,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Colomer,"

Phrase: "V.,"

Phrase: "Duan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kushi,"

Phrase: "J.,"

Phrase: "Kaminsky,"

Phrase: "Z.,"

Phrase: "Kieiderlein,"

Phrase: "J.J.,"

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.322: (1998) Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Atrophin-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380757:atrophin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1540211:ATROPHIN 1 [Gene or Genome]

Phrase: "the DRPLA gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1540211:DRPLA GENE [Gene or Genome]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "interacts with two families of WW domain-containing proteins."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   745   C0162808:Protein Domain [Spatial Concept]
   745   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0015576:Families [Family Group]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205448:Two [Quantitative Concept]
   742   C0332256:Containing [Functional Concept]
   742   C1704727:Family [Conceptual Entity]
   742   C1861696:WW [Disease or Syndrome]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C2700400:Containing [Activity]
   742   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.323: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.324: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.325: Neurosci., 11, 149160.[ISI][Medline] 22 Matilla, A., Koshy, B.T., Cummings, C.J., Isobe, T., Orr, H.T. and Zoghbi, H.Y. 

Phrase: "Neurosci.,"

Phrase: "11,"

Phrase: "149160."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 22 Matilla,"

Phrase: "A.,"

Phrase: "Koshy,"

Phrase: "B.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "Cummings,"

Phrase: "C.J.,"

Phrase: "Isobe,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Orr,"

Phrase: "H.T."

Phrase: "and"

Phrase: "Zoghbi,"

Phrase: "H.Y."
Processing 00000000.tx.326: (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. 

Phrase: "(1997"

Phrase: ")"

Phrase: "The cerebellar leucine-rich acidic nuclear protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   947   C1421894:LEUCINE-RICH ACIDIC NUCLEAR PROTEIN [Gene or Genome]
   827   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0521447:Nuclear [Spatial Concept]

Phrase: "interacts with ataxin-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1538298:ATAXIN 1 [Gene or Genome]
Processing 00000000.tx.327: Nature, 389, 974978.[ISI][Medline] 23 Watkins, J.F., Sung, P., Prakash, L. and Prakash, S. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "389,"

Phrase: "974978."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 23 Watkins,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Prakash,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Prakash,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.328: (1993) The Saccharomyces cerevisiae DNA repair gene RAD23 encodes a nuclear protein containing a ubiquitin-like domain required for biological function. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The Saccharomyces cerevisiae DNA repair gene RAD23"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a nuclear protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "required for biological function."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0031845:Biological function, NOS [Physiologic Function]
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0031843:function [Physiologic Function]
   770   C0205460:biological [Qualitative Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1514873:Required [Functional Concept]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.329: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.330: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.331: Biol., 13, 77577765.[Abstract] 24 Sugasawa, K., Ng, J.M.Y., Masutani, C., Maekawa, T., Uchida, A., van der Spek, P.J., Eker, A.P.M., Rademakers, S., Visser, C., Aboussekhra, A. et al. 

Phrase: "Biol.,"

Phrase: "13,"

Phrase: "77577765."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24 Sugasawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ng,"

Phrase: "J."

Phrase: "M."

Phrase: "Y.,"

Phrase: "Masutani,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Maekawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Uchida,"

Phrase: "A.,"

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.J.,"

Phrase: "Eker,"

Phrase: "A.P.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C2346751:A/m [Quantitative Concept]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Rademakers,"

Phrase: "S."

Phrase: ","

Phrase: "Visser,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Aboussekhra,"

Phrase: "A. et al."
Processing 00000000.tx.332: (1997) Two human homologs of rad23 are functionally interchangeable in complex formation and stimulation of XPC repair activity. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Two human homologs of rad23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1334043:Homolog [Gene or Genome]

Phrase: "are"

Phrase: "functionally interchangeable in complex formation"

Phrase: "and"

Phrase: "stimulation of XPC repair activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.333: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.334: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.335: Biol., 17, 69246931.[Abstract] 25 Sugasawa, K., Masutani, C., Uchida, A., Meakawa, T., van der Spek, P.J., Bootsma, D, Hoeijmakers, Jan, H.J. and Hanaoka, F. 

Phrase: "Biol.,"

Phrase: "17,"

Phrase: "69246931."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25 Sugasawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masutani,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Uchida,"

Phrase: "A.,"

Phrase: "Meakawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P.J.,"

Phrase: "Bootsma,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hoeijmakers,"

Phrase: "Jan,"

Phrase: "H.J."

Phrase: "and"

Phrase: "Hanaoka,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.336: (1996) HHR23B, a human rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. 

Phrase: "(1996"

Phrase: ")"

Phrase: "HHR23B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1419237:HHR23B [Gene or Genome]
  1000   C3539756:hHR23B [Amino Acid, Peptide, or Protein]
  1000   C3541311:HHR23B [Gene or Genome]

Phrase: "a human rad23 homolog,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1334043:Homolog [Gene or Genome]
   727 E C2697616:Homology [Qualitative Concept]

Phrase: "stimulates"

Phrase: "XPC protein in nucleotide excision repair"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   849   C1421540:xeroderma pigmentosum group C protein [Gene or Genome]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1159338:protein repair [Molecular Function]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.337: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.338: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.339: Biol., 16, 48524861.[Abstract] 26 Wang, G.-H., Mitsui, K., Kotliarova, S., Yamashita, A., Nagao, Y., Tokuhiro, S., Iwatsubo, T., Kanazawa, I. and Nukina, N. 

Phrase: "Biol.,"

Phrase: "16,"

Phrase: "48524861."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 26 Wang,"

Phrase: "G.-H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mitsui,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kotliarova,"

Phrase: "S."

Phrase: ","

Phrase: "Yamashita,"

Phrase: "A.,"

Phrase: "Nagao,"

Phrase: "Y.,"

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kanazawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nukina,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.340: (1999) Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Caspase activation during apoptotic cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1159825:Caspase Activation [Molecular Function]
   783   C1326120:cell activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "induced by expanded polyglutamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205229:expanded [Spatial Concept]
   770   C0205263:Induced [Functional Concept]
   770   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]

Phrase: "in N2a cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.341: Neuroreport, 10, 24352438.[ISI][Medline] 27 Hiyama, H., Yokoi, M., Masutani, C., Sugasawa, K., Kaekawa, T., Tanaka, K., Hoeijmakers, J.H.J. and Hanaoka, F. 

Phrase: "Neuroreport,"

Phrase: "10,"

Phrase: "24352438."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27 Hiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yokoi,"

Phrase: "M."

Phrase: ","

Phrase: "Masutani,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sugasawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaekawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hoeijmakers,"

Phrase: "J.H.J."

Phrase: "and"

Phrase: "Hanaoka,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.342: (1999) Interaction of hHR23 with S5a. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Interaction of hHR23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "with S5a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419034:S5A [Gene or Genome]
Processing 00000000.tx.343: The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26S proteasome. 

Phrase: "The ubiquitin-like domain of hHR23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "interaction with S5a subunit of 26S proteasome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514525:Proteasome Interaction [Molecular Function]
   748   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.344: J. 

Phrase: "J."
Processing 00000000.tx.345: Biol. 

Phrase: "Biol."
Processing 00000000.tx.346: Chem., 274, 2801928025.[Abstract/Free FullText] 28 Gragerov, A., Kino, T, Ilyina-Gragerova, G., Chrousos, G.P. and Pavlakis, G.N. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "2801928025."

Phrase: "[Abstract/Free FullText"

Phrase: "] 28 Gragerov,"

Phrase: "A.,"

Phrase: "Kino,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1011810:kino [Plant]
  1000   C1969618:KINO [Gene or Genome]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ilyina-Gragerova,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chrousos,"

Phrase: "G.P."

Phrase: "and"

Phrase: "Pavlakis,"

Phrase: "G.N."
Processing 00000000.tx.347: (1998) HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "HHR23A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419236:HHR23A [Gene or Genome]

Phrase: "the human homologue of the yeast repair protein RAD23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1334043:Homologue [Gene or Genome]

Phrase: "interacts"

Phrase: "specifically with Vpr protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0079405:vpr Protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0079423:VPR [Gene or Genome]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "cell cycle arrest"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155873:Cell Cycle Arrest [Cell Function]
  1000   C1516332:Cell Cycle Arrest [Cell Function]
   827   C0237477:Arrest [Temporal Concept]
   827   C0392351:arrest [Governmental or Regulatory Activity]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the transcriptional effects of Vpr."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.348: Virology, 245, 323330.[ISI][Medline] 29 Kumar, S., Talis, A.L. and Howley, P.M. 

Phrase: "Virology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042762:Virology [Biomedical Occupation or Discipline]
  1000   C0205466:virology [Functional Concept]

Phrase: "245,"

Phrase: "323330."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 29 Kumar,"

Phrase: "S."

Phrase: ","

Phrase: "Talis,"

Phrase: "A.L."

Phrase: "and"

Phrase: "Howley,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.349: (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Identification of HHR23A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "as a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "for E6-associated protein-mediated ubiquitination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C1519751:Protein Ubiquitination [Molecular Function]
           Ubiquitination
Processing 00000000.tx.350: J. 

Phrase: "J."
Processing 00000000.tx.351: Biol. 

Phrase: "Biol."
Processing 00000000.tx.352: Chem., 274, 1878518792.[Abstract/Free FullText] 30 Schauber, C., Chen, L., Tongaonkar, P., Vega, I., Lambertson, D., Potts, W. and Madura, K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "1878518792."

Phrase: "[Abstract/Free FullText"

Phrase: "] 30 Schauber,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tongaonkar,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vega,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lambertson,"

Phrase: "D."

Phrase: ","

Phrase: "Potts,"

Phrase: "W."

Phrase: "and"

Phrase: "Madura,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205804:Madoera [Geographic Area]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.353: (1998) Rad23 links DNA repair to the ubiquitin/proteasome pathway. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Rad23"

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "DNA repair to the ubiquitin/proteasome pathway."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1511689:DNA Repair Pathway [Conceptual Entity]
   778   C0012899:DNA Repair [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0043240:Repair, NOS [Organism Function]
   748   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.354: Nature, 391, 715718.[ISI][Medline] 31 Russell, S.J., Reed, S.H., Huang, W., Friedberg, E.C. and Johnston, S.A. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "391,"

Phrase: "715718."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 31 Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979971:Russell [Laboratory Procedure]

Phrase: "S."

Phrase: "J.,"

Phrase: "Reed,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "W.,"

Phrase: "Friedberg,"

Phrase: "E.C."

Phrase: "and"

Phrase: "Johnston,"

Phrase: "S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.355: (1999) The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The 19S regulatory complex of the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "functions independently of proteolysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0597304:Proteolysis [Molecular Function]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "in nucleotide excision repair."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0524550:Nucleotide Excision Repair [Genetic Function]
  1000   C2984260:Nucleotide excision repair [Functional Concept]
   901   C0015249:Excision Repair [Genetic Function]
   827   C0015252:excision [Therapeutic or Preventive Procedure]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0043240:Repair, NOS [Organism Function]
   827   C0374711:Repair [Therapeutic or Preventive Procedure]
   827   C0728940:Excision [Therapeutic or Preventive Procedure]
Processing 00000000.tx.356: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.357: Cell, 3, 687695.[ISI][Medline] 32 Iwabuchi, K., Li, B., Bartel, P. and Fields, S. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "687695."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 32 Iwabuchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bartel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966   C1521738:Field [Conceptual Entity]
   966   C2346620:Field [Conceptual Entity]
   966   C2349184:Field [Conceptual Entity]
   966   C3539073:FIELD [Spatial Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.358: (1993) Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Use of the two-hybrid system to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0599647:Two Hybrid [Molecular Biology Research Technique]
   778   C1524063:Use of [Functional Concept]
   748   C0020205:Hybrid [Organism]
   748   C0042153:use [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0449913:System [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1947944:Use [Intellectual Product]

Phrase: "identify"

Phrase: "the domain of p53"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C3541951:Domain [Intellectual Product]

Phrase: "involved in oligomerization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.359: Oncogene, 8, 16931696.[ISI][Medline] 33 Li, B. and Fields, S. 

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "8,"

Phrase: "16931696."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 33 Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966   C1521738:Field [Conceptual Entity]
   966   C2346620:Field [Conceptual Entity]
   966   C2349184:Field [Conceptual Entity]
   966   C3539073:FIELD [Spatial Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.360: (1993) Identification of mutations in p53 that affect its binding to SV40 T antigen by using the yeast two-hybrid system. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Identification of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "in p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its binding to SV40 T antigen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1148575:antigen binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid system."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
           Two Hybrid
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.361: FASEB J., 7, 957963.[Abstract/Free FullText]

Phrase: "FASEB J.,"

Phrase: "7,"

Phrase: "957963."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

